---
title: "Pancreatic Cancer survival 2.3 X more likely if good level of Vitamin D – meta-analysis"
slug: "pancreatic-cancer-survival-23-x-more-likely-if-good-level-of-vitamin-d-meta-analysis"
aliases:
  - "/Pancreatic+Cancer+survival+23+X+more+likely+if+good+level+of+Vitamin+D+–+meta-analysis+Sept+2023"
  - "/tiki-index.php?page_id=14683"
date: 2023-09-15
categories:
  - "Cancer - Pancreatic"
  - "Meta-analysis of Vitamin D"
---



<!-- {maketoc Title=""} -->

---

### There are 2 meta-analyses on this page

---

#### 25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis - 2023

Nutrition Research Vol 117, Sept 2023, Pages 73-82 [https://doi.org/10.1016/j.nutres.2023.07.001](https://doi.org/10.1016/j.nutres.2023.07.001) PDF is behind a paywall

Jing Li a #, Haiyan Zhang a #, Hongda Zhu b, Zhu Dai a

Studies have shown that 25-hydroxyvitamin D (25(OH)D) is predictive of survival following a diagnosis of cancer. However, evidence of the relationship between 25(OH)D and the survival of patients with pancreatic cancer has been inconsistent. We hypothesized that circulating 25(OH)D concentrations may be positively correlated with better prognosis in advanced pancreatic cancer. PubMed, EMBASE, Cochrane Library, and Web of Science database entries through April 2023, along with the reference lists of related studies, were searched. Additionally, we extracted observational studies reporting the association between 25(OH)D concentrations and the outcome of interest (overall survival <span>[OS]</span>) in advanced pancreatic cancer patients aged 18 years or older. Ultimately, 7 articles involving 2369 patients were included in this systematic review and meta-analysis. The results indicated that 25(OH)D concentrations were positively correlated with  **OS (hazard ratio = 2.37** ; 95% confidence interval, 2.22–2.54; P < .001). No association was found between 25(OH)D and progression-free survival. There was significant heterogeneity between studies in terms of OS (I2 = 85.5%, P < .001). Our subgroup analysis revealed that this high heterogeneity may be attributed to the studies’ different regions, designs, sample sources, and detection methods of 25(OH)D. Additionally, Begg's and Egger's tests indicated the presence of publication bias. To our knowledge, this is the first meta-analysis to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer. Our results suggested that circulating 25(OH)D concentrations were positively correlated with OS, indicating that 25(OH)D may be a potential prognostic marker in advanced pancreatic cancer.

Graphical abstract

This systematic review and meta-analysis was performed to evaluate the association between circulating 25-hydroxyvitamin D (25(OH)D) concentration and survival outcomes among patients with advanced pancreatic cancer. The results showed that 25(OH)D concentrations were positively correlated with overall survival among patients with pancreatic cancer, indicating that 25(OH)D concentration may be a potential prognostic marker in advanced pancreatic cancer.

Introduction

Pancreatic cancer is considered a fatal disease and is 1 of the most aggressive and deadly types of malignant tumors <sup>[1]</sup>. It has been reported that the 5-year survival rate of patients with pancreatic cancer varies in different regions and countries in the world; however, these rates have consistently remained below 10% <sup>[2]</sup>. This is partly because pancreatic cancer tends to metastasize to lymph nodes or distant sites at an early stage because of its high capacity for invasion and migration <sup>[3]</sup>. To date, except for the onset stage, there are few known patient characteristics or circulating markers that can predict the survival time of patients with pancreatic cancer.

The classical role of vitamin D (VD) is to maintain calcium homeostasis and help regulate bone metabolism <sup>[4]</sup>. Initially, it was considered to have autocrine and paracrine effects until the discovery that multiple cells throughout the body can express both vitamin D receptors (VDRs) and the hydroxylase necessary to produce calcitriol <sup>[5]</sup>. VD is predominantly synthesized from 7-dehydrocholesterol in the skin on exposure to sunlight, whereas the remaining VD is obtained from dietary sources. VD itself has low activity at physiological concentrations and requires 2 successive hydroxylation reactions. It is first metabolized by 25-hydroxylase (CYP2R1 and CYP27A1) to 25-hydroxyvitamin D (25(OH)D) in the liver. Notably, 25(OH)D is the primary circulating form of VD and a clinical marker. Subsequently, 25(OH)D is further metabolized by 1α-hydroxylase, mainly in the proximal tubule of the kidney, to 1α,25-dihydroxyvitamin D <sup>[6]</sup>, the most biologically active form of VD. It can bind to VDRs that influence target genes involved in intracellular signaling pathways, including cell growth, differentiation, adhesion, and apoptosis <sup>[7]</sup>. This altered cellular mechanism plays a key role in cancer development and suggests a potential relationship between VD and cancer.

Multiple experimental studies have indicated that VD participates in pancreatic carcinogenesis and demonstrated the therapeutic potential of VD analogs via the engagement of VDRs in tumor and supportive cells within the tumor stroma <sup>[8,9]</sup>. Notably, an inverse association between serum 25(OH)D concentration and risk for cancer has been commonly reported in epidemiological studies <sup>[10]</sup>. Additionally, there is widespread interest in evaluating the association between circulating 25(OH)D and patient prognosis. Some clinical studies have revealed longer overall survival (OS) in patients with pancreatic cancer and sufficient 25(OH)D concentrations <sup>[11]</sup>. However, the results of this type of study were inconsistent with those of other studies, showing no significant relationship between circulating 25(OH)D concentrations and survival outcomes <sup>[12]</sup>.

Therefore, to assess the effect of 25(OH)D on survival outcomes in advanced pancreatic cancer patients, we performed a systematic review and meta-analysis to evaluate the association between circulating 25(OH)D concentrations and OS. We hypothesized that 25(OH)D concentrations may be positively correlated with OS in advanced pancreatic cancer.

##### Section snippets

Literature search

We searched PubMed, EMBASE, Web of Science, and Cochrane library databases (on April 2023) for cohort studies assessing the association between circulating 25(OH)D concentrations and OS in patients with advanced pancreatic cancers. Medical Subject Headings including “Pancreatic Neoplasms” and “Vitamin D” were used to choose qualified studies, and these were further combined with keyword searches in titles and abstracts. Additionally, the references cited in all selected studies and published…

Study selection

A flowchart of the study retrieval process is shown in Fig. 1. A total of 2166 potential studies were identified from the initial search of the previously mentioned databases, of which 538 were duplicates. After removing duplicate records and screening the titles and abstracts, 846 records remained. The full-text documents of these records were assessed, resulting in the exclusion of  **839 records** . The exclusion criteria were as follows: (1) review articles (n = 445); (2) animal experiments (n…

Discussion

This meta-analysis is the first to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer and to assess the potential prognostic value of 25(OH)D. Our results supported the notion that a positive correlation existed between 25(OH)D and OS in patients with pancreatic cancer, which was consistent with our hypothesis.

Pancreatic cancer is a prevalent disease characterized by a low survival rate, primarily because it is often detected at advanced stages, …

Conclusion

In conclusion, our study indicated that 25(OH)D concentrations were positively correlated with OS, which may provide useful prognostic information for advanced pancreatic cancer patients. However, more studies are needed to validate this finding, and the mechanism behind the observation should be evaluated in further studies…

---

##### Some titles of references

* Vitamin D and pancreatic cancer

* Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications

* Vitamin D for cancer prevention: global perspective

* Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number

* The vitamin D system is deregulated in pancreatic diseases

* Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis

* Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study

* The vitamin D dose response in obesity

* High prevalence of vitamin D deficiency in urban health checkup population

* Vitamin D, parathyroid hormone, and cardiovascular events among older adults

* Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in t 47d breast cancer cells

* Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression

* Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease

* Current epidemiology of pancreatic cancer: challenges and opportunities

* Pancreatic cancer: a review of epidemiology, trend, and risk factors

* Pancreatic cancer: a review of current treatment and novel therapies

* Vitamin D binding protein and bone health

* Sex differences in vitamin D metabolism, serum levels and action

* Calcipotriol targets lrp6 to inhibit wnt signaling in pancreatic cancer

* Activation of vitamin D receptor signaling downregulates the expression of nuclear foxm1 protein and suppresses pancreatic cancer cell stemness

* Vitamin D for the prevention and treatment of pancreatic cancer

* Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival

---

#### 40% less likely to die of Pancreatic Cancer if high vitamin D - meta-analyis Jan 2024

 **The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies** 

Eur J Nutr. 2024 Jan 3. doi: [10.1007/s00394-023-03302-w](10.1007/s00394-023-03302-w) PDF behind paywall

Yajing Shen 1 2, Junfen Xia 3, Chuncheng Yi 1 2, Tiandong Li 1 2, Peng Wang 1 2, Liping Dai 2 4, Jianxiang Shi 2 4, Keyan Wang 2 4, Changqing Sun 1 5, Hua Ye 6 7

Purpose: The relationship between circulating 25-hydroxyvitamin D <span>[25(OH)D]</span> and pancreatic cancer has been well studied but remains unclear. The purpose of this study was to elucidate the association between circulating 25(OH)D and pancreatic cancer by using a meta-analytic approach.

Methods: PubMed, Embase, and Wed of Science databases were searched through October 15, 2022. A random or fixed-effects model was used to estimate the pooled odds ratio (OR), risk ratio (RR), hazard ratio (HR) and their 95% confidence intervals (CIs).

Results: A total of 16 studies including 529,917 participants met the inclusion criteria, of which 10 reported incidence and 6 reported mortality. For the highest versus lowest categories of circulating 25(OH)D, the pooled OR of pancreatic cancer incidence in case-control studies was 0.98 (95% CI 0.69-1.27), and the pooled HRs of pancreatic cancer mortality in cohort and case-control studies were  **0.64**  (95% CI 0.45-0.82) and 0.78 (95% CI 0.62-0.95), respectively. The leave-one-out sensitivity analyses found no outliers and Galbraith plots indicated no substantial heterogeneity.

Conclusion: Evidence from this meta-analysis suggested that high circulating 25(OH)D levels may be associated with decreased mortality but not incidence of pancreatic cancer. Our findings may provide some clues for the treatment of pancreatic cancer and remind us to be cautious about widespread vitamin D supplementation for the prevention of pancreatic cancer.

##### 95 References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed

1. Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48. https://doi.org/10.3322/caac.21763 - DOI - PubMed

1. You L, Lv Z, Li C, Ye W, Zhou Y, Jin J, Han Q (2021) Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019. ESMO Open 6:100255. https://doi.org/10.1016/j.esmoop.2021.100255 - DOI - PubMed - PMC

1. Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010) Preoperative/neoadjuvant therapy in **pancreatic cancer** : a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267. https://doi.org/10.1371/journal.pmed.1000267 - DOI - PubMed - PMC

1. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005 - DOI - PubMed

1. Tempero MA (2019) NCCN guidelines updates: **pancreatic cancer** . J Natl Compr Canc Netw 17:603–605. https://doi.org/10.6004/jnccn.2019.5007 - DOI - PubMed

1. Clinton SK, Giovannucci EL, Hursting SD (2020) The World Cancer Research Fund/American Institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr 150:663–671. https://doi.org/10.1093/jn/nxz268 - DOI - PubMed

1. Qin X, Chen J, Jia G, Yang Z (2023) Dietary factors and **pancreatic cancer**  risk: an umbrella review of meta-analyses of prospective observational studies. Adv Nutr 14:451–464. https://doi.org/10.1016/j.advnut.2023.02.004 - DOI - PubMed - PMC

1. Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S et al (1993) A cohort study of smoking, alcohol consumption, and dietary factors for **pancreatic cancer**  (United States). Cancer Causes Control 4:477–482. https://doi.org/10.1007/bf00050867 - DOI - PubMed

1. Peila R, Coday M, Crane TE, Saquib N, Shadyab AH, Tabung FK, Zhang X et al (2022) Healthy lifestyle index and risk of **pancreatic cancer**  in the women’s health initiative. Cancer Causes Control 33:737–747. https://doi.org/10.1007/s10552-022-01558-x - DOI - PubMed - PMC

1. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2003) Dietary meat, dairy products, fat, and cholesterol and **pancreatic cancer**  risk in a prospective study. Am J Epidemiol 157:1115–1125. https://doi.org/10.1093/aje/kwg098 - DOI - PubMed

1. Chatterjee R, Fuss P, Vickery EM, LeBlanc ES, Sheehan PR, Lewis MR, Dolor RJ et al (2021)  **vitamin**  D supplementation for prevention of cancer: the D2d cancer outcomes (D2dCA) ancillary study. J Clin Endocrinol Metab 106:2767–2778. https://doi.org/10.1210/clinem/dgab153 - DOI - PubMed - PMC

1. Haykal T, Samji V, Zayed Y, Gakhal I, Dhillon H, Kheiri B, Kerbage J et al (2019) The role of  **vitamin**  D supplementation for primary prevention of cancer: meta-analysis of randomized controlled trials. J Community Hosp Internal Med Persp 9:480–488. https://doi.org/10.1080/20009666.2019.1701839 - DOI

1. Reid IR, Bolland MJ, Grey A (2014) Effects of  **vitamin**  D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146–155. https://doi.org/10.1016/s0140-6736(13)61647-5 - DOI - PubMed

1. Vanhevel J, Verlinden L, Doms S, Wildiers H, Verstuyf A (2022) The role of  **vitamin**  D in breast cancer risk and progression. Endocr Relat Cancer 29:R33-r55. https://doi.org/10.1530/erc-21-0182 - DOI - PubMed

1. Kim H, Lipsyc-Sharf M, Zong X, Wang X, Hur J, Song M, Wang M et al (2021) Total  **vitamin**  D intake and risks of early-onset colorectal cancer and precursors. Gastroenterology 161:1208-1217.e9. https://doi.org/10.1053/j.gastro.2021.07.002 - DOI - PubMed

1. Kanaan Y, Copeland RL (2022) The link between  **vitamin**  D and prostate cancer. Nat Rev Cancer 22:435. https://doi.org/10.1038/s41568-022-00493-y - DOI - PubMed

1. Jones G (2013) Extrarenal  **vitamin**  D activation and interactions between  **vitamin**  D2,  **vitamin**  D3, and  **vitamin**  D analogs. Annu Rev Nutr 33:23–44. https://doi.org/10.1146/annurev-nutr-071812-161203 - DOI - PubMed

1. Wilson LR, Tripkovic L, Hart KH, Lanham-New SA (2017)  **vitamin**  D deficiency as a public health issue: using  **vitamin**  D2 or  **vitamin**  D3 in future fortification strategies. Proc Nutr Soc 76:392–399. https://doi.org/10.1017/s0029665117000349 - DOI - PubMed

1. Holick MF (2004)  **vitamin**  D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371. https://doi.org/10.1093/ajcn/79.3.362 - DOI - PubMed

1. Green J (1951) Studies on the analysis of  **vitamin** s D. 4. Studies on the irradiation of ergosterol and 7-dehydrocholesterol and the analysis of the products for calciferol,  **vitamin**  D3, and component sterols. Biochem J 49:232–243. https://doi.org/10.1042/bj0490232 - DOI - PubMed - PMC

1. Bikle DD (2014)  **vitamin**  D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329. https://doi.org/10.1016/j.chembiol.2013.12.016 - DOI - PubMed - PMC

1. Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG (2014)  **vitamin**  D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2:298–306. https://doi.org/10.1016/s2213-8587(13)70200-6 - DOI - PubMed

1. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD et al (2013) Causal relationship between obesity and  **vitamin**  D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383. https://doi.org/10.1371/journal.pmed.1001383 - DOI - PubMed - PMC

1. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of  **vitamin**  D in obesity. Am J Clin Nutr 72:690–693. https://doi.org/10.1093/ajcn/72.3.690 - DOI - PubMed

1. Savastano S, Barrea L, Savanelli MC, Nappi F, Di Somma C, Orio F, Colao A (2017) Low  **vitamin**  D status and obesity: role of nutritionist. Rev Endocr Metab Disord 18:215–225. https://doi.org/10.1007/s11154-017-9410-7 - DOI - PubMed

1. Fernandes MR, Barreto WDRJ (2017) Association between physical activity and  **vitamin**  D: a narrative literature review. Rev Assoc Med Bras (1993) 63:550–556. https://doi.org/10.1590/1806-9282.63.06.550 - DOI

1. Bicakli DH, Uslu R, Güney SC, Coker A (2020) The relationship between nutritional status, performance status, and survival among **pancreatic cancer**  patients. Nutr Cancer 72:202–208. https://doi.org/10.1080/01635581.2019.1634217 - DOI - PubMed

1. Kubiak J, Kamycheva E, Jorde R (2021) Tracking of serum 25-hydroxy **vitamin**  D during 21 years. Eur J Clin Nutr 75:1069–1076. https://doi.org/10.1038/s41430-020-00814-0 - DOI - PubMed

1. Borel P, Caillaud D, Cano NJ (2015)  **vitamin**  D bioavailability: state of the art. Crit Rev Food Sci Nutr 55:1193–1205. https://doi.org/10.1080/10408398.2012.688897 - DOI - PubMed

1. Stolzenberg-Solomon RZ (2009)  **vitamin**  D and **pancreatic cancer** . Ann Epidemiol 19:89–95. https://doi.org/10.1016/j.annepidem.2008.03.010 - DOI - PubMed

1. Sanchez GV, Weinstein SJ, Stolzenberg-Solomon RZ (2012) Is dietary fat,  **vitamin**  D, or folate associated with **pancreatic cancer** ? Mol Carcinog 51:119–127. https://doi.org/10.1002/mc.20833 - DOI - PubMed - PMC

1. Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC (2010) Ultraviolet B irradiance and  **vitamin**  D status are inversely associated with incidence rates of **pancreatic cancer**  worldwide. Pancreas 39:669–674. https://doi.org/10.1097/MPA.0b013e3181ce654d - DOI - PubMed

1. Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted  **vitamin**  D status and **pancreatic cancer**  risk in two prospective cohort studies. Br J Cancer 102:1422–1427. https://doi.org/10.1038/sj.bjc.6605658 - DOI - PubMed - PMC

1. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (2006) Prospective study of predictors of  **vitamin**  D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459. https://doi.org/10.1093/jnci/djj101 - DOI - PubMed

1. Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, Ng K et al (2016) Prediagnostic plasma 25-hydroxy **vitamin**  D and **pancreatic cancer**  survival. J Clin Oncol 34:2899–2905. https://doi.org/10.1200/jco.2015.66.3005 - DOI - PubMed - PMC

1. Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP et al (2004) **pancreatic cancer**  cells express 25-hydroxy **vitamin**  D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxy **vitamin**  D3. Carcinogenesis 25:1015–1026. https://doi.org/10.1093/carcin/bgh086 - DOI - PubMed

1. Pettersson F, Colston KW, Dalgleish AG (2000) Differential and antagonistic effects of 9-cis-retinoic acid and  **vitamin**  D analogues on **pancreatic cancer**  cells in vitro. Br J Cancer 83:239–245. https://doi.org/10.1054/bjoc.2000.1281 - DOI - PubMed - PMC

1. Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T et al (1996) Inhibitory effect of 220-oxa-1,25-dihydroxy **vitamin**  D3 on the proliferation of **pancreatic cancer**  cell lines. Gastroenterology 110:1605–1613. https://doi.org/10.1053/gast.1996.v110.pm8613068 - DOI - PubMed

1. Colston KW, James SY, Ofori-Kuragu EA, Binderup L, Grant AG (1997)  **vitamin**  D receptors and anti-proliferative effects of  **vitamin**  D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 76:1017–1020. https://doi.org/10.1038/bjc.1997.501 - DOI - PubMed - PMC

1. van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, Kampman E et al (2018) Circulating concentrations of  **vitamin**  D in relation to **pancreatic cancer**  risk in European populations. Int J Cancer 142:1189–1201. https://doi.org/10.1002/ijc.31146 - DOI - PubMed

1. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ et al (2010) Circulating 25-hydroxy **vitamin**  D and risk of **pancreatic cancer** : cohort consortium  **vitamin**  D pooling project of rarer cancers. Am J Epidemiol 172:81–93. https://doi.org/10.1093/aje/kwq120 - DOI - PubMed - PMC

1. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012) Impact of circulating  **vitamin**  D binding protein levels on the association between 25-hydroxy **vitamin**  D and **pancreatic cancer**  risk: a nested case-control study. Cancer Res 72:1190–1198. https://doi.org/10.1158/0008-5472.Can-11-2950 - DOI - PubMed - PMC

1. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D et al (2000) Meta-analysis of observational studies in epidemiology—ā proposal for reporting. Jama-J Am Med Assoc 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008 - DOI

1. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71 - DOI - PubMed - PMC

1. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD - DOI

1. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z - DOI - PubMed

1. Institute of Medicine Committee to Review Dietary Reference Intakes for  **vitamin**  D, Calcium (2011) The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press (US) Copyright © 2011, National Academy of Sciences., Washington (DC)

1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH et al (2011) Evaluation, treatment, and prevention of  **vitamin**  D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930. https://doi.org/10.1210/jc.2011-0385 - DOI - PubMed

1. Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, Cooper C et al (2022) Role of  **vitamin**  D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res 34:2603–2623. https://doi.org/10.1007/s40520-022-02279-6 - DOI - PubMed - PMC

1. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxy **vitamin**  D for multiple health outcomes. Am J Clin Nutr 84:18–28. https://doi.org/10.1093/ajcn/84.1.18 - DOI - PubMed

1. DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139–145. https://doi.org/10.1016/j.cct.2015.09.002 - DOI - PubMed - PMC

1. DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15:1237–48. https://doi.org/10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N - DOI - PubMed

1. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2 - DOI - PubMed

1. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557 - DOI - PubMed - PMC

1. Jeon SM, Shin EA (2018) Exploring  **vitamin**  D metabolism and function in cancer. Exp Mol Med 50:1–14. https://doi.org/10.1038/s12276-018-0038-9 - DOI - PubMed

1. Marigoudar JB, Sarkar D, Yuguda YM, Abutayeh RF, Kaur A, Pati A, Mitra D et al (2022) Role of  **vitamin**  D in targeting cancer and cancer stem cell populations and its therapeutic implications. Med Oncol 40:2. https://doi.org/10.1007/s12032-022-01855-0 - DOI - PubMed

1. Chiang KC, Chen TC (2009)  **vitamin**  D for the prevention and treatment of **pancreatic cancer** . World J Gastroenterol 15:3349–3354. https://doi.org/10.3748/wjg.15.3349 - DOI - PubMed - PMC

1. Mondul AM, Weinstein SJ, Layne TM, Albanes D (2017)  **vitamin**  D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev 39:28–48. https://doi.org/10.1093/epirev/mxx005 - DOI - PubMed - PMC

1. Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of **pancreatic cancer** . J Natl Cancer Inst 105:1027–1035. https://doi.org/10.1093/jnci/djt123 - DOI - PubMed - PMC

1. Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A (2010) 25-Hydroxy **vitamin**  D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18:1906–1910. https://doi.org/10.1038/oby.2010.11 - DOI - PubMed

1. Vaidya A, Williams JS, Forman JP (2012) The independent association between 25-hydroxy **vitamin**  D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) 20:186–191. https://doi.org/10.1038/oby.2011.210 - DOI - PubMed

1. Earthman CP, Beckman LM, Masodkar K, Sibley SD (2012) The link between obesity and low circulating 25-hydroxy **vitamin**  D concentrations: considerations and implications. Int J Obes (Lond) 36:387–396. https://doi.org/10.1038/ijo.2011.119 - DOI - PubMed

1. McPhail S, Johnson S, Greenberg D, Peake M, Rous B (2015) Stage at diagnosis and early mortality from cancer in England. Br J Cancer 112(Suppl 1):S108–S115. https://doi.org/10.1038/bjc.2015.49 - DOI - PubMed - PMC

1. Zwaigenbaum L, Stone W (2008) Early detection. Autism 12:427–432. https://doi.org/10.1177/1362361308097836 - DOI - PubMed

1. Fernández-Lázaro D, Seco-Calvo J (2023) Nutrition, nutritional status and functionality. Nutrients. https://doi.org/10.3390/nu15081944 - DOI - PubMed - PMC

1. Zhang X, Chen Y, Jin S, Bi X, Chen D, Zhang D, Liu L et al (2020) Association of serum 25-Hydroxy **vitamin**  D with  **vitamin**  D intervention and outdoor activity among children in North China: an observational study. BMC Pediatr 20:542. https://doi.org/10.1186/s12887-020-02435-9 - DOI - PubMed - PMC

1. Holick MF (2017) The  **vitamin**  D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18:153–165. https://doi.org/10.1007/s11154-017-9424-1 - DOI - PubMed

1. Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, Stolzenberg-Solomon RZ et al (2018) Circulating 25-hydroxy **vitamin**  D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol 33:1087–1099. https://doi.org/10.1007/s10654-018-0428-2 - DOI - PubMed - PMC

1. Rasmussen LS, Yilmaz MK, Falkmer UG, Poulsen L, Bøgsted M, Christensen HS, Bojesen SE et al (2021) Pre-treatment serum  **vitamin**  D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with **pancreatic cancer** . Eur J Cancer 144:72–80. https://doi.org/10.1016/j.ejca.2020.10.038 - DOI - PubMed

1. Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, Schulz C et al (2015) Assessing novel prognostic serum biomarkers in advanced **pancreatic cancer** : the role of CYFRA 21–1, serum amyloid A, haptoglobin, and 25-OH  **vitamin**  D3. Tumour Biol 36:2631–2640. https://doi.org/10.1007/s13277-014-2885-x - DOI - PubMed

1. McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB (2016) Retrospective analysis of the influence of 25-hydroxy **vitamin**  D on disease progression and survival in **pancreatic cancer** . Nutr J 15:17. https://doi.org/10.1186/s12937-016-0135-3 - DOI - PubMed - PMC

1. LeFevre ML (2015) Screening for  **vitamin**  D deficiency in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 162:133–140. https://doi.org/10.7326/m14-2450 - DOI - PubMed

1. Kantor ED, Rehm CD, Du M, White E, Giovannucci EL (2016) Trends in dietary supplement use among US adults from 1999–2012. JAMA 316:1464–1474. https://doi.org/10.1001/jama.2016.14403 - DOI - PubMed - PMC

1. Adams JS, Hewison M (2012) Extrarenal expression of the 25-hydroxy **vitamin**  D-1-hydroxylase. Arch Biochem Biophys 523:95–102. https://doi.org/10.1016/j.abb.2012.02.016 - DOI - PubMed - PMC

1. Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C (1996) Growth-inhibitory effects of  **vitamin**  D analogues and retinoids on human **pancreatic cancer**  cells. Br J Cancer 73:1341–1346. https://doi.org/10.1038/bjc.1996.256 - DOI - PubMed - PMC

1. Schwartz GG, Eads D, Naczki C, Northrup S, Chen T, Koumenis C (2008) 19-nor-1 alpha,25-dihydroxy **vitamin**  D2 (paricalcitol) inhibits the proliferation of human **pancreatic cancer**  cells in vitro and in vivo. Cancer Biol Ther 7:430–436. https://doi.org/10.4161/cbt.7.3.5418 - DOI - PubMed

1. Albrechtsson E, Jonsson T, Möller S, Höglund M, Ohlsson B, Axelson J (2003)  **vitamin**  D receptor is expressed in **pancreatic cancer**  cells and a  **vitamin**  D3 analogue decreases cell number. Pancreatology 3:41–46. https://doi.org/10.1159/000069149 - DOI - PubMed

1. Armas LA, Hollis BW, Heaney RP (2004)  **vitamin**  D2 is much less effective than  **vitamin**  D3 in humans. J Clin Endocrinol Metab 89:5387–5391. https://doi.org/10.1210/jc.2004-0360 - DOI - PubMed

1. Skinner HG (2008)  **vitamin**  D for the treatment and prevention of **pancreatic cancer** . Cancer Biol Ther 7:437–439. https://doi.org/10.4161/cbt.7.3.5585 - DOI - PubMed

1. Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA et al (2014)  **vitamin**  D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances **pancreatic cancer**  therapy. Cell 159:80–93. https://doi.org/10.1016/j.cell.2014.08.007 - DOI - PubMed - PMC

1. Hennig R, Ding XZ, Adrian TE (2004) On the role of the islets of Langerhans in **pancreatic cancer** . Histol Histopathol 19:999–1011. https://doi.org/10.14670/hh-19.999

1. Bear AS, Vonderheide RH, O’Hara MH (2020) Challenges and opportunities for **pancreatic cancer**  immunotherapy. Cancer Cell 38:788–802. https://doi.org/10.1016/j.ccell.2020.08.004 - DOI - PubMed - PMC

1. Maestro B, Molero S, Bajo S, Dávila N, Calle C (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxy **vitamin**  D(3). Cell Biochem Funct 20:227–232. https://doi.org/10.1002/cbf.951 - DOI - PubMed

1. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxy **vitamin**  D3 receptors in human leukocytes. Science 221:1181–1183. https://doi.org/10.1126/science.6310748 - DOI - PubMed

1. Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxy **vitamin**  D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657–661. https://doi.org/10.1172/jci111465 - DOI - PubMed - PMC

1. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxy **vitamin**  D3 on human B cell differentiation. J Immunol 179:1634–1647. https://doi.org/10.4049/jimmunol.179.3.1634 - DOI - PubMed

1. Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of  **vitamin**  D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932. https://doi.org/10.1002/jcb.10580 - DOI - PubMed

1. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010)  **vitamin**  D: modulator of the immune system. Curr Opin Pharmacol 10:482–496. https://doi.org/10.1016/j.coph.2010.04.001 - DOI - PubMed

1. Mora JR, Iwata M, von Andrian UH (2008)  **vitamin**  effects on the immune system:  **vitamin** s A and D take centre stage. Nat Rev Immunol 8:685–698. https://doi.org/10.1038/nri2378 - DOI - PubMed - PMC

1. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC (1985) 1,25-Dihydroxy **vitamin**  D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134:3032–3035 - DOI - PubMed

1. Schlingmann KP (2021)  **vitamin**  D-dependent Hypercalcemia. Endocrinol Metab Clin North Am 50:729–742. https://doi.org/10.1016/j.ecl.2021.08.005 - DOI - PubMed

1. Tebben PJ, Singh RJ, Kumar R (2016)  **vitamin**  D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37:521–547. https://doi.org/10.1210/er.2016-1070 - DOI - PubMed - PMC

1. Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S et al (2009) Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice–the ECHO observational study. Nephrol Dial Transpl 24:2852–2859. https://doi.org/10.1093/ndt/gfp144 - DOI

1. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ et al (2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70:351–357. https://doi.org/10.1038/sj.ki.5001542 - DOI - PubMed

---

#### VitaminDWiki – [Cancer - Pancreatic](/categories/cancer---pancreatic) category contains

---

####  <span style="color:orange;">81+</span>  VitaminDWiki Cancer meta-analyses

This list is automatically updated

{LIST()}

{list max="150"}

<!-- {filter categories="82"} -->

<!-- {filter field="title" content="cancer"} -->

<!-- {filter type="wiki page"} -->

{sort mode="modification_date_major_desc"}

{OUTPUT(template="table")}

   {tableparams allowtableexpansion="n" shownbitems="y" title=""}n

    {column sort="title" label="Title" field="title" mode="raw"}{column}

    {column label="Modified" sort="modification_date_major" field="modification_date_major"}

{OUTPUT}

{FORMAT(name="title")}{display name=title format="objectlink"}{FORMAT}

{FORMAT(name="modification_date_major")}{display name=modification_date_major format="date"}{FORMAT}

{LIST}

<!-- ~tc~ (alias(Pancreatic Cancer survival 2.3 X more likely if good level of Vitamin D – meta-analysis  Sept 2023)) ~/tc~ -->


<pre style="background-color: #e0e0e0;">
<code class="language-text">
Markdown:
--------

&lt;!-- {maketoc Title=&quot;&quot;} --&gt;

---

### There are 2 meta-analyses on this page

---

#### 25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis - 2023

Nutrition Research Vol 117, Sept 2023, Pages 73-82 [https://doi.org/10.1016/j.nutres.2023.07.001](https://doi.org/10.1016/j.nutres.2023.07.001) PDF is behind a paywall

Jing Li a #, Haiyan Zhang a #, Hongda Zhu b, Zhu Dai a

Studies have shown that 25-hydroxyvitamin D (25(OH)D) is predictive of survival following a diagnosis of cancer. However, evidence of the relationship between 25(OH)D and the survival of patients with pancreatic cancer has been inconsistent. We hypothesized that circulating 25(OH)D concentrations may be positively correlated with better prognosis in advanced pancreatic cancer. PubMed, EMBASE, Cochrane Library, and Web of Science database entries through April 2023, along with the reference lists of related studies, were searched. Additionally, we extracted observational studies reporting the association between 25(OH)D concentrations and the outcome of interest (overall survival &lt;span&gt;[OS]&lt;/span&gt;) in advanced pancreatic cancer patients aged 18 years or older. Ultimately, 7 articles involving 2369 patients were included in this systematic review and meta-analysis. The results indicated that 25(OH)D concentrations were positively correlated with  **OS (hazard ratio = 2.37** ; 95% confidence interval, 2.22–2.54; P &lt; .001). No association was found between 25(OH)D and progression-free survival. There was significant heterogeneity between studies in terms of OS (I2 = 85.5%, P &lt; .001). Our subgroup analysis revealed that this high heterogeneity may be attributed to the studies’ different regions, designs, sample sources, and detection methods of 25(OH)D. Additionally, Begg&#39;s and Egger&#39;s tests indicated the presence of publication bias. To our knowledge, this is the first meta-analysis to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer. Our results suggested that circulating 25(OH)D concentrations were positively correlated with OS, indicating that 25(OH)D may be a potential prognostic marker in advanced pancreatic cancer.

Graphical abstract

This systematic review and meta-analysis was performed to evaluate the association between circulating 25-hydroxyvitamin D (25(OH)D) concentration and survival outcomes among patients with advanced pancreatic cancer. The results showed that 25(OH)D concentrations were positively correlated with overall survival among patients with pancreatic cancer, indicating that 25(OH)D concentration may be a potential prognostic marker in advanced pancreatic cancer.

Introduction

Pancreatic cancer is considered a fatal disease and is 1 of the most aggressive and deadly types of malignant tumors &lt;sup&gt;[1]&lt;/sup&gt;. It has been reported that the 5-year survival rate of patients with pancreatic cancer varies in different regions and countries in the world; however, these rates have consistently remained below 10% &lt;sup&gt;[2]&lt;/sup&gt;. This is partly because pancreatic cancer tends to metastasize to lymph nodes or distant sites at an early stage because of its high capacity for invasion and migration &lt;sup&gt;[3]&lt;/sup&gt;. To date, except for the onset stage, there are few known patient characteristics or circulating markers that can predict the survival time of patients with pancreatic cancer.

The classical role of vitamin D (VD) is to maintain calcium homeostasis and help regulate bone metabolism &lt;sup&gt;[4]&lt;/sup&gt;. Initially, it was considered to have autocrine and paracrine effects until the discovery that multiple cells throughout the body can express both vitamin D receptors (VDRs) and the hydroxylase necessary to produce calcitriol &lt;sup&gt;[5]&lt;/sup&gt;. VD is predominantly synthesized from 7-dehydrocholesterol in the skin on exposure to sunlight, whereas the remaining VD is obtained from dietary sources. VD itself has low activity at physiological concentrations and requires 2 successive hydroxylation reactions. It is first metabolized by 25-hydroxylase (CYP2R1 and CYP27A1) to 25-hydroxyvitamin D (25(OH)D) in the liver. Notably, 25(OH)D is the primary circulating form of VD and a clinical marker. Subsequently, 25(OH)D is further metabolized by 1α-hydroxylase, mainly in the proximal tubule of the kidney, to 1α,25-dihydroxyvitamin D &lt;sup&gt;[6]&lt;/sup&gt;, the most biologically active form of VD. It can bind to VDRs that influence target genes involved in intracellular signaling pathways, including cell growth, differentiation, adhesion, and apoptosis &lt;sup&gt;[7]&lt;/sup&gt;. This altered cellular mechanism plays a key role in cancer development and suggests a potential relationship between VD and cancer.

Multiple experimental studies have indicated that VD participates in pancreatic carcinogenesis and demonstrated the therapeutic potential of VD analogs via the engagement of VDRs in tumor and supportive cells within the tumor stroma &lt;sup&gt;[8,9]&lt;/sup&gt;. Notably, an inverse association between serum 25(OH)D concentration and risk for cancer has been commonly reported in epidemiological studies &lt;sup&gt;[10]&lt;/sup&gt;. Additionally, there is widespread interest in evaluating the association between circulating 25(OH)D and patient prognosis. Some clinical studies have revealed longer overall survival (OS) in patients with pancreatic cancer and sufficient 25(OH)D concentrations &lt;sup&gt;[11]&lt;/sup&gt;. However, the results of this type of study were inconsistent with those of other studies, showing no significant relationship between circulating 25(OH)D concentrations and survival outcomes &lt;sup&gt;[12]&lt;/sup&gt;.

Therefore, to assess the effect of 25(OH)D on survival outcomes in advanced pancreatic cancer patients, we performed a systematic review and meta-analysis to evaluate the association between circulating 25(OH)D concentrations and OS. We hypothesized that 25(OH)D concentrations may be positively correlated with OS in advanced pancreatic cancer.

##### Section snippets

Literature search

We searched PubMed, EMBASE, Web of Science, and Cochrane library databases (on April 2023) for cohort studies assessing the association between circulating 25(OH)D concentrations and OS in patients with advanced pancreatic cancers. Medical Subject Headings including “Pancreatic Neoplasms” and “Vitamin D” were used to choose qualified studies, and these were further combined with keyword searches in titles and abstracts. Additionally, the references cited in all selected studies and published…

Study selection

A flowchart of the study retrieval process is shown in Fig. 1. A total of 2166 potential studies were identified from the initial search of the previously mentioned databases, of which 538 were duplicates. After removing duplicate records and screening the titles and abstracts, 846 records remained. The full-text documents of these records were assessed, resulting in the exclusion of  **839 records** . The exclusion criteria were as follows: (1) review articles (n = 445); (2) animal experiments (n…

Discussion

This meta-analysis is the first to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer and to assess the potential prognostic value of 25(OH)D. Our results supported the notion that a positive correlation existed between 25(OH)D and OS in patients with pancreatic cancer, which was consistent with our hypothesis.

Pancreatic cancer is a prevalent disease characterized by a low survival rate, primarily because it is often detected at advanced stages, …

Conclusion

In conclusion, our study indicated that 25(OH)D concentrations were positively correlated with OS, which may provide useful prognostic information for advanced pancreatic cancer patients. However, more studies are needed to validate this finding, and the mechanism behind the observation should be evaluated in further studies…

---

##### Some titles of references

* Vitamin D and pancreatic cancer

* Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications

* Vitamin D for cancer prevention: global perspective

* Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number

* The vitamin D system is deregulated in pancreatic diseases

* Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis

* Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study

* The vitamin D dose response in obesity

* High prevalence of vitamin D deficiency in urban health checkup population

* Vitamin D, parathyroid hormone, and cardiovascular events among older adults

* Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in t 47d breast cancer cells

* Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression

* Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease

* Current epidemiology of pancreatic cancer: challenges and opportunities

* Pancreatic cancer: a review of epidemiology, trend, and risk factors

* Pancreatic cancer: a review of current treatment and novel therapies

* Vitamin D binding protein and bone health

* Sex differences in vitamin D metabolism, serum levels and action

* Calcipotriol targets lrp6 to inhibit wnt signaling in pancreatic cancer

* Activation of vitamin D receptor signaling downregulates the expression of nuclear foxm1 protein and suppresses pancreatic cancer cell stemness

* Vitamin D for the prevention and treatment of pancreatic cancer

* Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival

---

#### 40% less likely to die of Pancreatic Cancer if high vitamin D - meta-analyis Jan 2024

 **The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies** 

Eur J Nutr. 2024 Jan 3. doi: [10.1007/s00394-023-03302-w](10.1007/s00394-023-03302-w) PDF behind paywall

Yajing Shen 1 2, Junfen Xia 3, Chuncheng Yi 1 2, Tiandong Li 1 2, Peng Wang 1 2, Liping Dai 2 4, Jianxiang Shi 2 4, Keyan Wang 2 4, Changqing Sun 1 5, Hua Ye 6 7

Purpose: The relationship between circulating 25-hydroxyvitamin D &lt;span&gt;[25(OH)D]&lt;/span&gt; and pancreatic cancer has been well studied but remains unclear. The purpose of this study was to elucidate the association between circulating 25(OH)D and pancreatic cancer by using a meta-analytic approach.

Methods: PubMed, Embase, and Wed of Science databases were searched through October 15, 2022. A random or fixed-effects model was used to estimate the pooled odds ratio (OR), risk ratio (RR), hazard ratio (HR) and their 95% confidence intervals (CIs).

Results: A total of 16 studies including 529,917 participants met the inclusion criteria, of which 10 reported incidence and 6 reported mortality. For the highest versus lowest categories of circulating 25(OH)D, the pooled OR of pancreatic cancer incidence in case-control studies was 0.98 (95% CI 0.69-1.27), and the pooled HRs of pancreatic cancer mortality in cohort and case-control studies were  **0.64**  (95% CI 0.45-0.82) and 0.78 (95% CI 0.62-0.95), respectively. The leave-one-out sensitivity analyses found no outliers and Galbraith plots indicated no substantial heterogeneity.

Conclusion: Evidence from this meta-analysis suggested that high circulating 25(OH)D levels may be associated with decreased mortality but not incidence of pancreatic cancer. Our findings may provide some clues for the treatment of pancreatic cancer and remind us to be cautious about widespread vitamin D supplementation for the prevention of pancreatic cancer.

##### 95 References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed

1. Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48. https://doi.org/10.3322/caac.21763 - DOI - PubMed

1. You L, Lv Z, Li C, Ye W, Zhou Y, Jin J, Han Q (2021) Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019. ESMO Open 6:100255. https://doi.org/10.1016/j.esmoop.2021.100255 - DOI - PubMed - PMC

1. Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010) Preoperative/neoadjuvant therapy in **pancreatic cancer** : a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267. https://doi.org/10.1371/journal.pmed.1000267 - DOI - PubMed - PMC

1. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005 - DOI - PubMed

1. Tempero MA (2019) NCCN guidelines updates: **pancreatic cancer** . J Natl Compr Canc Netw 17:603–605. https://doi.org/10.6004/jnccn.2019.5007 - DOI - PubMed

1. Clinton SK, Giovannucci EL, Hursting SD (2020) The World Cancer Research Fund/American Institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr 150:663–671. https://doi.org/10.1093/jn/nxz268 - DOI - PubMed

1. Qin X, Chen J, Jia G, Yang Z (2023) Dietary factors and **pancreatic cancer**  risk: an umbrella review of meta-analyses of prospective observational studies. Adv Nutr 14:451–464. https://doi.org/10.1016/j.advnut.2023.02.004 - DOI - PubMed - PMC

1. Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S et al (1993) A cohort study of smoking, alcohol consumption, and dietary factors for **pancreatic cancer**  (United States). Cancer Causes Control 4:477–482. https://doi.org/10.1007/bf00050867 - DOI - PubMed

1. Peila R, Coday M, Crane TE, Saquib N, Shadyab AH, Tabung FK, Zhang X et al (2022) Healthy lifestyle index and risk of **pancreatic cancer**  in the women’s health initiative. Cancer Causes Control 33:737–747. https://doi.org/10.1007/s10552-022-01558-x - DOI - PubMed - PMC

1. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2003) Dietary meat, dairy products, fat, and cholesterol and **pancreatic cancer**  risk in a prospective study. Am J Epidemiol 157:1115–1125. https://doi.org/10.1093/aje/kwg098 - DOI - PubMed

1. Chatterjee R, Fuss P, Vickery EM, LeBlanc ES, Sheehan PR, Lewis MR, Dolor RJ et al (2021)  **vitamin**  D supplementation for prevention of cancer: the D2d cancer outcomes (D2dCA) ancillary study. J Clin Endocrinol Metab 106:2767–2778. https://doi.org/10.1210/clinem/dgab153 - DOI - PubMed - PMC

1. Haykal T, Samji V, Zayed Y, Gakhal I, Dhillon H, Kheiri B, Kerbage J et al (2019) The role of  **vitamin**  D supplementation for primary prevention of cancer: meta-analysis of randomized controlled trials. J Community Hosp Internal Med Persp 9:480–488. https://doi.org/10.1080/20009666.2019.1701839 - DOI

1. Reid IR, Bolland MJ, Grey A (2014) Effects of  **vitamin**  D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146–155. https://doi.org/10.1016/s0140-6736(13)61647-5 - DOI - PubMed

1. Vanhevel J, Verlinden L, Doms S, Wildiers H, Verstuyf A (2022) The role of  **vitamin**  D in breast cancer risk and progression. Endocr Relat Cancer 29:R33-r55. https://doi.org/10.1530/erc-21-0182 - DOI - PubMed

1. Kim H, Lipsyc-Sharf M, Zong X, Wang X, Hur J, Song M, Wang M et al (2021) Total  **vitamin**  D intake and risks of early-onset colorectal cancer and precursors. Gastroenterology 161:1208-1217.e9. https://doi.org/10.1053/j.gastro.2021.07.002 - DOI - PubMed

1. Kanaan Y, Copeland RL (2022) The link between  **vitamin**  D and prostate cancer. Nat Rev Cancer 22:435. https://doi.org/10.1038/s41568-022-00493-y - DOI - PubMed

1. Jones G (2013) Extrarenal  **vitamin**  D activation and interactions between  **vitamin**  D2,  **vitamin**  D3, and  **vitamin**  D analogs. Annu Rev Nutr 33:23–44. https://doi.org/10.1146/annurev-nutr-071812-161203 - DOI - PubMed

1. Wilson LR, Tripkovic L, Hart KH, Lanham-New SA (2017)  **vitamin**  D deficiency as a public health issue: using  **vitamin**  D2 or  **vitamin**  D3 in future fortification strategies. Proc Nutr Soc 76:392–399. https://doi.org/10.1017/s0029665117000349 - DOI - PubMed

1. Holick MF (2004)  **vitamin**  D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371. https://doi.org/10.1093/ajcn/79.3.362 - DOI - PubMed

1. Green J (1951) Studies on the analysis of  **vitamin** s D. 4. Studies on the irradiation of ergosterol and 7-dehydrocholesterol and the analysis of the products for calciferol,  **vitamin**  D3, and component sterols. Biochem J 49:232–243. https://doi.org/10.1042/bj0490232 - DOI - PubMed - PMC

1. Bikle DD (2014)  **vitamin**  D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329. https://doi.org/10.1016/j.chembiol.2013.12.016 - DOI - PubMed - PMC

1. Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG (2014)  **vitamin**  D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2:298–306. https://doi.org/10.1016/s2213-8587(13)70200-6 - DOI - PubMed

1. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD et al (2013) Causal relationship between obesity and  **vitamin**  D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383. https://doi.org/10.1371/journal.pmed.1001383 - DOI - PubMed - PMC

1. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of  **vitamin**  D in obesity. Am J Clin Nutr 72:690–693. https://doi.org/10.1093/ajcn/72.3.690 - DOI - PubMed

1. Savastano S, Barrea L, Savanelli MC, Nappi F, Di Somma C, Orio F, Colao A (2017) Low  **vitamin**  D status and obesity: role of nutritionist. Rev Endocr Metab Disord 18:215–225. https://doi.org/10.1007/s11154-017-9410-7 - DOI - PubMed

1. Fernandes MR, Barreto WDRJ (2017) Association between physical activity and  **vitamin**  D: a narrative literature review. Rev Assoc Med Bras (1993) 63:550–556. https://doi.org/10.1590/1806-9282.63.06.550 - DOI

1. Bicakli DH, Uslu R, Güney SC, Coker A (2020) The relationship between nutritional status, performance status, and survival among **pancreatic cancer**  patients. Nutr Cancer 72:202–208. https://doi.org/10.1080/01635581.2019.1634217 - DOI - PubMed

1. Kubiak J, Kamycheva E, Jorde R (2021) Tracking of serum 25-hydroxy **vitamin**  D during 21 years. Eur J Clin Nutr 75:1069–1076. https://doi.org/10.1038/s41430-020-00814-0 - DOI - PubMed

1. Borel P, Caillaud D, Cano NJ (2015)  **vitamin**  D bioavailability: state of the art. Crit Rev Food Sci Nutr 55:1193–1205. https://doi.org/10.1080/10408398.2012.688897 - DOI - PubMed

1. Stolzenberg-Solomon RZ (2009)  **vitamin**  D and **pancreatic cancer** . Ann Epidemiol 19:89–95. https://doi.org/10.1016/j.annepidem.2008.03.010 - DOI - PubMed

1. Sanchez GV, Weinstein SJ, Stolzenberg-Solomon RZ (2012) Is dietary fat,  **vitamin**  D, or folate associated with **pancreatic cancer** ? Mol Carcinog 51:119–127. https://doi.org/10.1002/mc.20833 - DOI - PubMed - PMC

1. Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC (2010) Ultraviolet B irradiance and  **vitamin**  D status are inversely associated with incidence rates of **pancreatic cancer**  worldwide. Pancreas 39:669–674. https://doi.org/10.1097/MPA.0b013e3181ce654d - DOI - PubMed

1. Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted  **vitamin**  D status and **pancreatic cancer**  risk in two prospective cohort studies. Br J Cancer 102:1422–1427. https://doi.org/10.1038/sj.bjc.6605658 - DOI - PubMed - PMC

1. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (2006) Prospective study of predictors of  **vitamin**  D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459. https://doi.org/10.1093/jnci/djj101 - DOI - PubMed

1. Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, Ng K et al (2016) Prediagnostic plasma 25-hydroxy **vitamin**  D and **pancreatic cancer**  survival. J Clin Oncol 34:2899–2905. https://doi.org/10.1200/jco.2015.66.3005 - DOI - PubMed - PMC

1. Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP et al (2004) **pancreatic cancer**  cells express 25-hydroxy **vitamin**  D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxy **vitamin**  D3. Carcinogenesis 25:1015–1026. https://doi.org/10.1093/carcin/bgh086 - DOI - PubMed

1. Pettersson F, Colston KW, Dalgleish AG (2000) Differential and antagonistic effects of 9-cis-retinoic acid and  **vitamin**  D analogues on **pancreatic cancer**  cells in vitro. Br J Cancer 83:239–245. https://doi.org/10.1054/bjoc.2000.1281 - DOI - PubMed - PMC

1. Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T et al (1996) Inhibitory effect of 220-oxa-1,25-dihydroxy **vitamin**  D3 on the proliferation of **pancreatic cancer**  cell lines. Gastroenterology 110:1605–1613. https://doi.org/10.1053/gast.1996.v110.pm8613068 - DOI - PubMed

1. Colston KW, James SY, Ofori-Kuragu EA, Binderup L, Grant AG (1997)  **vitamin**  D receptors and anti-proliferative effects of  **vitamin**  D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 76:1017–1020. https://doi.org/10.1038/bjc.1997.501 - DOI - PubMed - PMC

1. van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, Kampman E et al (2018) Circulating concentrations of  **vitamin**  D in relation to **pancreatic cancer**  risk in European populations. Int J Cancer 142:1189–1201. https://doi.org/10.1002/ijc.31146 - DOI - PubMed

1. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ et al (2010) Circulating 25-hydroxy **vitamin**  D and risk of **pancreatic cancer** : cohort consortium  **vitamin**  D pooling project of rarer cancers. Am J Epidemiol 172:81–93. https://doi.org/10.1093/aje/kwq120 - DOI - PubMed - PMC

1. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012) Impact of circulating  **vitamin**  D binding protein levels on the association between 25-hydroxy **vitamin**  D and **pancreatic cancer**  risk: a nested case-control study. Cancer Res 72:1190–1198. https://doi.org/10.1158/0008-5472.Can-11-2950 - DOI - PubMed - PMC

1. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D et al (2000) Meta-analysis of observational studies in epidemiology—ā proposal for reporting. Jama-J Am Med Assoc 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008 - DOI

1. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71 - DOI - PubMed - PMC

1. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD - DOI

1. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z - DOI - PubMed

1. Institute of Medicine Committee to Review Dietary Reference Intakes for  **vitamin**  D, Calcium (2011) The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press (US) Copyright © 2011, National Academy of Sciences., Washington (DC)

1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH et al (2011) Evaluation, treatment, and prevention of  **vitamin**  D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930. https://doi.org/10.1210/jc.2011-0385 - DOI - PubMed

1. Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, Cooper C et al (2022) Role of  **vitamin**  D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res 34:2603–2623. https://doi.org/10.1007/s40520-022-02279-6 - DOI - PubMed - PMC

1. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxy **vitamin**  D for multiple health outcomes. Am J Clin Nutr 84:18–28. https://doi.org/10.1093/ajcn/84.1.18 - DOI - PubMed

1. DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139–145. https://doi.org/10.1016/j.cct.2015.09.002 - DOI - PubMed - PMC

1. DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15:1237–48. https://doi.org/10.1002/(SICI)1097-0258(19960630)15:12&lt;1237::AID-SIM301&gt;3.0.CO;2-N - DOI - PubMed

1. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2 - DOI - PubMed

1. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557 - DOI - PubMed - PMC

1. Jeon SM, Shin EA (2018) Exploring  **vitamin**  D metabolism and function in cancer. Exp Mol Med 50:1–14. https://doi.org/10.1038/s12276-018-0038-9 - DOI - PubMed

1. Marigoudar JB, Sarkar D, Yuguda YM, Abutayeh RF, Kaur A, Pati A, Mitra D et al (2022) Role of  **vitamin**  D in targeting cancer and cancer stem cell populations and its therapeutic implications. Med Oncol 40:2. https://doi.org/10.1007/s12032-022-01855-0 - DOI - PubMed

1. Chiang KC, Chen TC (2009)  **vitamin**  D for the prevention and treatment of **pancreatic cancer** . World J Gastroenterol 15:3349–3354. https://doi.org/10.3748/wjg.15.3349 - DOI - PubMed - PMC

1. Mondul AM, Weinstein SJ, Layne TM, Albanes D (2017)  **vitamin**  D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev 39:28–48. https://doi.org/10.1093/epirev/mxx005 - DOI - PubMed - PMC

1. Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of **pancreatic cancer** . J Natl Cancer Inst 105:1027–1035. https://doi.org/10.1093/jnci/djt123 - DOI - PubMed - PMC

1. Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A (2010) 25-Hydroxy **vitamin**  D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18:1906–1910. https://doi.org/10.1038/oby.2010.11 - DOI - PubMed

1. Vaidya A, Williams JS, Forman JP (2012) The independent association between 25-hydroxy **vitamin**  D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) 20:186–191. https://doi.org/10.1038/oby.2011.210 - DOI - PubMed

1. Earthman CP, Beckman LM, Masodkar K, Sibley SD (2012) The link between obesity and low circulating 25-hydroxy **vitamin**  D concentrations: considerations and implications. Int J Obes (Lond) 36:387–396. https://doi.org/10.1038/ijo.2011.119 - DOI - PubMed

1. McPhail S, Johnson S, Greenberg D, Peake M, Rous B (2015) Stage at diagnosis and early mortality from cancer in England. Br J Cancer 112(Suppl 1):S108–S115. https://doi.org/10.1038/bjc.2015.49 - DOI - PubMed - PMC

1. Zwaigenbaum L, Stone W (2008) Early detection. Autism 12:427–432. https://doi.org/10.1177/1362361308097836 - DOI - PubMed

1. Fernández-Lázaro D, Seco-Calvo J (2023) Nutrition, nutritional status and functionality. Nutrients. https://doi.org/10.3390/nu15081944 - DOI - PubMed - PMC

1. Zhang X, Chen Y, Jin S, Bi X, Chen D, Zhang D, Liu L et al (2020) Association of serum 25-Hydroxy **vitamin**  D with  **vitamin**  D intervention and outdoor activity among children in North China: an observational study. BMC Pediatr 20:542. https://doi.org/10.1186/s12887-020-02435-9 - DOI - PubMed - PMC

1. Holick MF (2017) The  **vitamin**  D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18:153–165. https://doi.org/10.1007/s11154-017-9424-1 - DOI - PubMed

1. Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, Stolzenberg-Solomon RZ et al (2018) Circulating 25-hydroxy **vitamin**  D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol 33:1087–1099. https://doi.org/10.1007/s10654-018-0428-2 - DOI - PubMed - PMC

1. Rasmussen LS, Yilmaz MK, Falkmer UG, Poulsen L, Bøgsted M, Christensen HS, Bojesen SE et al (2021) Pre-treatment serum  **vitamin**  D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with **pancreatic cancer** . Eur J Cancer 144:72–80. https://doi.org/10.1016/j.ejca.2020.10.038 - DOI - PubMed

1. Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, Schulz C et al (2015) Assessing novel prognostic serum biomarkers in advanced **pancreatic cancer** : the role of CYFRA 21–1, serum amyloid A, haptoglobin, and 25-OH  **vitamin**  D3. Tumour Biol 36:2631–2640. https://doi.org/10.1007/s13277-014-2885-x - DOI - PubMed

1. McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB (2016) Retrospective analysis of the influence of 25-hydroxy **vitamin**  D on disease progression and survival in **pancreatic cancer** . Nutr J 15:17. https://doi.org/10.1186/s12937-016-0135-3 - DOI - PubMed - PMC

1. LeFevre ML (2015) Screening for  **vitamin**  D deficiency in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 162:133–140. https://doi.org/10.7326/m14-2450 - DOI - PubMed

1. Kantor ED, Rehm CD, Du M, White E, Giovannucci EL (2016) Trends in dietary supplement use among US adults from 1999–2012. JAMA 316:1464–1474. https://doi.org/10.1001/jama.2016.14403 - DOI - PubMed - PMC

1. Adams JS, Hewison M (2012) Extrarenal expression of the 25-hydroxy **vitamin**  D-1-hydroxylase. Arch Biochem Biophys 523:95–102. https://doi.org/10.1016/j.abb.2012.02.016 - DOI - PubMed - PMC

1. Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C (1996) Growth-inhibitory effects of  **vitamin**  D analogues and retinoids on human **pancreatic cancer**  cells. Br J Cancer 73:1341–1346. https://doi.org/10.1038/bjc.1996.256 - DOI - PubMed - PMC

1. Schwartz GG, Eads D, Naczki C, Northrup S, Chen T, Koumenis C (2008) 19-nor-1 alpha,25-dihydroxy **vitamin**  D2 (paricalcitol) inhibits the proliferation of human **pancreatic cancer**  cells in vitro and in vivo. Cancer Biol Ther 7:430–436. https://doi.org/10.4161/cbt.7.3.5418 - DOI - PubMed

1. Albrechtsson E, Jonsson T, Möller S, Höglund M, Ohlsson B, Axelson J (2003)  **vitamin**  D receptor is expressed in **pancreatic cancer**  cells and a  **vitamin**  D3 analogue decreases cell number. Pancreatology 3:41–46. https://doi.org/10.1159/000069149 - DOI - PubMed

1. Armas LA, Hollis BW, Heaney RP (2004)  **vitamin**  D2 is much less effective than  **vitamin**  D3 in humans. J Clin Endocrinol Metab 89:5387–5391. https://doi.org/10.1210/jc.2004-0360 - DOI - PubMed

1. Skinner HG (2008)  **vitamin**  D for the treatment and prevention of **pancreatic cancer** . Cancer Biol Ther 7:437–439. https://doi.org/10.4161/cbt.7.3.5585 - DOI - PubMed

1. Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA et al (2014)  **vitamin**  D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances **pancreatic cancer**  therapy. Cell 159:80–93. https://doi.org/10.1016/j.cell.2014.08.007 - DOI - PubMed - PMC

1. Hennig R, Ding XZ, Adrian TE (2004) On the role of the islets of Langerhans in **pancreatic cancer** . Histol Histopathol 19:999–1011. https://doi.org/10.14670/hh-19.999

1. Bear AS, Vonderheide RH, O’Hara MH (2020) Challenges and opportunities for **pancreatic cancer**  immunotherapy. Cancer Cell 38:788–802. https://doi.org/10.1016/j.ccell.2020.08.004 - DOI - PubMed - PMC

1. Maestro B, Molero S, Bajo S, Dávila N, Calle C (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxy **vitamin**  D(3). Cell Biochem Funct 20:227–232. https://doi.org/10.1002/cbf.951 - DOI - PubMed

1. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxy **vitamin**  D3 receptors in human leukocytes. Science 221:1181–1183. https://doi.org/10.1126/science.6310748 - DOI - PubMed

1. Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxy **vitamin**  D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657–661. https://doi.org/10.1172/jci111465 - DOI - PubMed - PMC

1. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxy **vitamin**  D3 on human B cell differentiation. J Immunol 179:1634–1647. https://doi.org/10.4049/jimmunol.179.3.1634 - DOI - PubMed

1. Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of  **vitamin**  D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932. https://doi.org/10.1002/jcb.10580 - DOI - PubMed

1. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010)  **vitamin**  D: modulator of the immune system. Curr Opin Pharmacol 10:482–496. https://doi.org/10.1016/j.coph.2010.04.001 - DOI - PubMed

1. Mora JR, Iwata M, von Andrian UH (2008)  **vitamin**  effects on the immune system:  **vitamin** s A and D take centre stage. Nat Rev Immunol 8:685–698. https://doi.org/10.1038/nri2378 - DOI - PubMed - PMC

1. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC (1985) 1,25-Dihydroxy **vitamin**  D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134:3032–3035 - DOI - PubMed

1. Schlingmann KP (2021)  **vitamin**  D-dependent Hypercalcemia. Endocrinol Metab Clin North Am 50:729–742. https://doi.org/10.1016/j.ecl.2021.08.005 - DOI - PubMed

1. Tebben PJ, Singh RJ, Kumar R (2016)  **vitamin**  D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37:521–547. https://doi.org/10.1210/er.2016-1070 - DOI - PubMed - PMC

1. Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S et al (2009) Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice–the ECHO observational study. Nephrol Dial Transpl 24:2852–2859. https://doi.org/10.1093/ndt/gfp144 - DOI

1. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ et al (2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70:351–357. https://doi.org/10.1038/sj.ki.5001542 - DOI - PubMed

---

#### VitaminDWiki – [Cancer - Pancreatic](/categories/cancer---pancreatic) category contains

---

####  &lt;span style=&quot;color:orange;&quot;&gt;81+&lt;/span&gt;  VitaminDWiki Cancer meta-analyses

This list is automatically updated

{LIST()}

{list max=&quot;150&quot;}

&lt;!-- {filter categories=&quot;82&quot;} --&gt;

&lt;!-- {filter field=&quot;title&quot; content=&quot;cancer&quot;} --&gt;

&lt;!-- {filter type=&quot;wiki page&quot;} --&gt;

{sort mode=&quot;modification_date_major_desc&quot;}

{OUTPUT(template=&quot;table&quot;)}

   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}n

    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}

    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}

{OUTPUT}

{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}

{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}

{LIST}

&lt;!-- ~tc~ (alias(Pancreatic Cancer survival 2.3 X more likely if good level of Vitamin D – meta-analysis  Sept 2023)) ~/tc~ --&gt;


AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!There are 2 meta-analyses on this page`
│   inner_content: `There are 2 meta-analyses on this page`
│   level: `3`
│   children:
│   ├── TextNode
│   │   full_match: `There are 2 meta-analyses on this page`
│   │   inner_content: `There are 2 meta-analyses on this page`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis - 2023`
│   inner_content: `25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis - 2023`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis - 2023`
│   │   inner_content: `25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis - 2023`├── TextNode
│   full_match: `\nNutrition Research Vol 117, Sept 2023, Pages 73-82 `
│   inner_content: `\nNutrition Research Vol 117, Sept 2023, Pages 73-82 `├── LinkNode
│   full_match: `[https://doi.org/10.1016/j.nutres.2023.07.001]`
│   inner_content: `https://doi.org/10.1016/j.nutres.2023.07.001`
│   url: `https://doi.org/10.1016/j.nutres.2023.07.001`
│   children:
│   ├── TextNode
│   │   full_match: `https://doi.org/10.1016/j.nutres.2023.07.001`
│   │   inner_content: `https://doi.org/10.1016/j.nutres.2023.07.001`├── TextNode
│   full_match: ` PDF is behind a paywall\nJing Li a #, Haiyan Zhang a #, Hongda Zhu b, Zhu Dai a\n\nStudies have shown that 25-hydroxyvitamin D (25(OH)D) is predictive of survival following a diagnosis of cancer. However, evidence of the relationship between 25(OH)D and the survival of patients with pancreatic cancer has been inconsistent. We hypothesized that circulating 25(OH)D concentrations may be positively correlated with better prognosis in advanced pancreatic cancer. PubMed, EMBASE, Cochrane Library, and Web of Science database entries through April 2023, along with the reference lists of related studies, were searched. Additionally, we extracted observational studies reporting the association between 25(OH)D concentrations and the outcome of interest (overall survival `
│   inner_content: ` PDF is behind a paywall\nJing Li a #, Haiyan Zhang a #, Hongda Zhu b, Zhu Dai a\n\nStudies have shown that 25-hydroxyvitamin D (25(OH)D) is predictive of survival following a diagnosis of cancer. However, evidence of the relationship between 25(OH)D and the survival of patients with pancreatic cancer has been inconsistent. We hypothesized that circulating 25(OH)D concentrations may be positively correlated with better prognosis in advanced pancreatic cancer. PubMed, EMBASE, Cochrane Library, and Web of Science database entries through April 2023, along with the reference lists of related studies, were searched. Additionally, we extracted observational studies reporting the association between 25(OH)D concentrations and the outcome of interest (overall survival `├── LinkNode
│   full_match: `[OS]`
│   inner_content: `OS`
│   url: `OS`
│   children:
│   ├── TextNode
│   │   full_match: `OS`
│   │   inner_content: `OS`├── TextNode
│   full_match: `) in advanced pancreatic cancer patients aged 18 years or older. Ultimately, 7 articles involving 2369 patients were included in this systematic review and meta-analysis. The results indicated that 25(OH)D concentrations were positively correlated with `
│   inner_content: `) in advanced pancreatic cancer patients aged 18 years or older. Ultimately, 7 articles involving 2369 patients were included in this systematic review and meta-analysis. The results indicated that 25(OH)D concentrations were positively correlated with `├── BoldNode
│   full_match: `__OS (hazard ratio = 2.37__`
│   inner_content: `OS (hazard ratio = 2.37`
│   children:
│   ├── TextNode
│   │   full_match: `OS (hazard ratio = 2.37`
│   │   inner_content: `OS (hazard ratio = 2.37`├── TextNode
│   full_match: `; 95% confidence interval, 2.22–2.54; P &lt; .001). No association was found between 25(OH)D and progression-free survival. There was significant heterogeneity between studies in terms of OS (I2 = 85.5%, P &lt; .001). Our subgroup analysis revealed that this high heterogeneity may be attributed to the studies’ different regions, designs, sample sources, and detection methods of 25(OH)D. Additionally, Begg&#39;s and Egger&#39;s tests indicated the presence of publication bias. To our knowledge, this is the first meta-analysis to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer. Our results suggested that circulating 25(OH)D concentrations were positively correlated with OS, indicating that 25(OH)D may be a potential prognostic marker in advanced pancreatic cancer.\n\nGraphical abstract\nThis systematic review and meta-analysis was performed to evaluate the association between circulating 25-hydroxyvitamin D (25(OH)D) concentration and survival outcomes among patients with advanced pancreatic cancer. The results showed that 25(OH)D concentrations were positively correlated with overall survival among patients with pancreatic cancer, indicating that 25(OH)D concentration may be a potential prognostic marker in advanced pancreatic cancer.\n\nIntroduction\nPancreatic cancer is considered a fatal disease and is 1 of the most aggressive and deadly types of malignant tumors `
│   inner_content: `; 95% confidence interval, 2.22–2.54; P &lt; .001). No association was found between 25(OH)D and progression-free survival. There was significant heterogeneity between studies in terms of OS (I2 = 85.5%, P &lt; .001). Our subgroup analysis revealed that this high heterogeneity may be attributed to the studies’ different regions, designs, sample sources, and detection methods of 25(OH)D. Additionally, Begg&#39;s and Egger&#39;s tests indicated the presence of publication bias. To our knowledge, this is the first meta-analysis to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer. Our results suggested that circulating 25(OH)D concentrations were positively correlated with OS, indicating that 25(OH)D may be a potential prognostic marker in advanced pancreatic cancer.\n\nGraphical abstract\nThis systematic review and meta-analysis was performed to evaluate the association between circulating 25-hydroxyvitamin D (25(OH)D) concentration and survival outcomes among patients with advanced pancreatic cancer. The results showed that 25(OH)D concentrations were positively correlated with overall survival among patients with pancreatic cancer, indicating that 25(OH)D concentration may be a potential prognostic marker in advanced pancreatic cancer.\n\nIntroduction\nPancreatic cancer is considered a fatal disease and is 1 of the most aggressive and deadly types of malignant tumors `├── LinkNode
│   full_match: `[1]`
│   inner_content: `1`
│   url: `1`
│   children:
│   ├── TextNode
│   │   full_match: `1`
│   │   inner_content: `1`├── TextNode
│   full_match: `. It has been reported that the 5-year survival rate of patients with pancreatic cancer varies in different regions and countries in the world; however, these rates have consistently remained below 10% `
│   inner_content: `. It has been reported that the 5-year survival rate of patients with pancreatic cancer varies in different regions and countries in the world; however, these rates have consistently remained below 10% `├── LinkNode
│   full_match: `[2]`
│   inner_content: `2`
│   url: `2`
│   children:
│   ├── TextNode
│   │   full_match: `2`
│   │   inner_content: `2`├── TextNode
│   full_match: `. This is partly because pancreatic cancer tends to metastasize to lymph nodes or distant sites at an early stage because of its high capacity for invasion and migration `
│   inner_content: `. This is partly because pancreatic cancer tends to metastasize to lymph nodes or distant sites at an early stage because of its high capacity for invasion and migration `├── LinkNode
│   full_match: `[3]`
│   inner_content: `3`
│   url: `3`
│   children:
│   ├── TextNode
│   │   full_match: `3`
│   │   inner_content: `3`├── TextNode
│   full_match: `. To date, except for the onset stage, there are few known patient characteristics or circulating markers that can predict the survival time of patients with pancreatic cancer.\n\nThe classical role of vitamin D (VD) is to maintain calcium homeostasis and help regulate bone metabolism `
│   inner_content: `. To date, except for the onset stage, there are few known patient characteristics or circulating markers that can predict the survival time of patients with pancreatic cancer.\n\nThe classical role of vitamin D (VD) is to maintain calcium homeostasis and help regulate bone metabolism `├── LinkNode
│   full_match: `[4]`
│   inner_content: `4`
│   url: `4`
│   children:
│   ├── TextNode
│   │   full_match: `4`
│   │   inner_content: `4`├── TextNode
│   full_match: `. Initially, it was considered to have autocrine and paracrine effects until the discovery that multiple cells throughout the body can express both vitamin D receptors (VDRs) and the hydroxylase necessary to produce calcitriol `
│   inner_content: `. Initially, it was considered to have autocrine and paracrine effects until the discovery that multiple cells throughout the body can express both vitamin D receptors (VDRs) and the hydroxylase necessary to produce calcitriol `├── LinkNode
│   full_match: `[5]`
│   inner_content: `5`
│   url: `5`
│   children:
│   ├── TextNode
│   │   full_match: `5`
│   │   inner_content: `5`├── TextNode
│   full_match: `. VD is predominantly synthesized from 7-dehydrocholesterol in the skin on exposure to sunlight, whereas the remaining VD is obtained from dietary sources. VD itself has low activity at physiological concentrations and requires 2 successive hydroxylation reactions. It is first metabolized by 25-hydroxylase (CYP2R1 and CYP27A1) to 25-hydroxyvitamin D (25(OH)D) in the liver. Notably, 25(OH)D is the primary circulating form of VD and a clinical marker. Subsequently, 25(OH)D is further metabolized by 1α-hydroxylase, mainly in the proximal tubule of the kidney, to 1α,25-dihydroxyvitamin D `
│   inner_content: `. VD is predominantly synthesized from 7-dehydrocholesterol in the skin on exposure to sunlight, whereas the remaining VD is obtained from dietary sources. VD itself has low activity at physiological concentrations and requires 2 successive hydroxylation reactions. It is first metabolized by 25-hydroxylase (CYP2R1 and CYP27A1) to 25-hydroxyvitamin D (25(OH)D) in the liver. Notably, 25(OH)D is the primary circulating form of VD and a clinical marker. Subsequently, 25(OH)D is further metabolized by 1α-hydroxylase, mainly in the proximal tubule of the kidney, to 1α,25-dihydroxyvitamin D `├── LinkNode
│   full_match: `[6]`
│   inner_content: `6`
│   url: `6`
│   children:
│   ├── TextNode
│   │   full_match: `6`
│   │   inner_content: `6`├── TextNode
│   full_match: `, the most biologically active form of VD. It can bind to VDRs that influence target genes involved in intracellular signaling pathways, including cell growth, differentiation, adhesion, and apoptosis `
│   inner_content: `, the most biologically active form of VD. It can bind to VDRs that influence target genes involved in intracellular signaling pathways, including cell growth, differentiation, adhesion, and apoptosis `├── LinkNode
│   full_match: `[7]`
│   inner_content: `7`
│   url: `7`
│   children:
│   ├── TextNode
│   │   full_match: `7`
│   │   inner_content: `7`├── TextNode
│   full_match: `. This altered cellular mechanism plays a key role in cancer development and suggests a potential relationship between VD and cancer.\n\nMultiple experimental studies have indicated that VD participates in pancreatic carcinogenesis and demonstrated the therapeutic potential of VD analogs via the engagement of VDRs in tumor and supportive cells within the tumor stroma `
│   inner_content: `. This altered cellular mechanism plays a key role in cancer development and suggests a potential relationship between VD and cancer.\n\nMultiple experimental studies have indicated that VD participates in pancreatic carcinogenesis and demonstrated the therapeutic potential of VD analogs via the engagement of VDRs in tumor and supportive cells within the tumor stroma `├── LinkNode
│   full_match: `[8,9]`
│   inner_content: `8,9`
│   url: `8,9`
│   children:
│   ├── TextNode
│   │   full_match: `8,9`
│   │   inner_content: `8,9`├── TextNode
│   full_match: `. Notably, an inverse association between serum 25(OH)D concentration and risk for cancer has been commonly reported in epidemiological studies `
│   inner_content: `. Notably, an inverse association between serum 25(OH)D concentration and risk for cancer has been commonly reported in epidemiological studies `├── LinkNode
│   full_match: `[10]`
│   inner_content: `10`
│   url: `10`
│   children:
│   ├── TextNode
│   │   full_match: `10`
│   │   inner_content: `10`├── TextNode
│   full_match: `. Additionally, there is widespread interest in evaluating the association between circulating 25(OH)D and patient prognosis. Some clinical studies have revealed longer overall survival (OS) in patients with pancreatic cancer and sufficient 25(OH)D concentrations `
│   inner_content: `. Additionally, there is widespread interest in evaluating the association between circulating 25(OH)D and patient prognosis. Some clinical studies have revealed longer overall survival (OS) in patients with pancreatic cancer and sufficient 25(OH)D concentrations `├── LinkNode
│   full_match: `[11]`
│   inner_content: `11`
│   url: `11`
│   children:
│   ├── TextNode
│   │   full_match: `11`
│   │   inner_content: `11`├── TextNode
│   full_match: `. However, the results of this type of study were inconsistent with those of other studies, showing no significant relationship between circulating 25(OH)D concentrations and survival outcomes `
│   inner_content: `. However, the results of this type of study were inconsistent with those of other studies, showing no significant relationship between circulating 25(OH)D concentrations and survival outcomes `├── LinkNode
│   full_match: `[12]`
│   inner_content: `12`
│   url: `12`
│   children:
│   ├── TextNode
│   │   full_match: `12`
│   │   inner_content: `12`├── TextNode
│   full_match: `.\n\nTherefore, to assess the effect of 25(OH)D on survival outcomes in advanced pancreatic cancer patients, we performed a systematic review and meta-analysis to evaluate the association between circulating 25(OH)D concentrations and OS. We hypothesized that 25(OH)D concentrations may be positively correlated with OS in advanced pancreatic cancer.\n`
│   inner_content: `.\n\nTherefore, to assess the effect of 25(OH)D on survival outcomes in advanced pancreatic cancer patients, we performed a systematic review and meta-analysis to evaluate the association between circulating 25(OH)D concentrations and OS. We hypothesized that 25(OH)D concentrations may be positively correlated with OS in advanced pancreatic cancer.\n`├── HeadingNode
│   full_match: `\n!!!!!Section snippets`
│   inner_content: `Section snippets`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Section snippets`
│   │   inner_content: `Section snippets`├── TextNode
│   full_match: `\nLiterature search\nWe searched PubMed, EMBASE, Web of Science, and Cochrane library databases (on April 2023) for cohort studies assessing the association between circulating 25(OH)D concentrations and OS in patients with advanced pancreatic cancers. Medical Subject Headings including “Pancreatic Neoplasms” and “Vitamin D” were used to choose qualified studies, and these were further combined with keyword searches in titles and abstracts. Additionally, the references cited in all selected studies and published…\n\nStudy selection\nA flowchart of the study retrieval process is shown in Fig. 1. A total of 2166 potential studies were identified from the initial search of the previously mentioned databases, of which 538 were duplicates. After removing duplicate records and screening the titles and abstracts, 846 records remained. The full-text documents of these records were assessed, resulting in the exclusion of `
│   inner_content: `\nLiterature search\nWe searched PubMed, EMBASE, Web of Science, and Cochrane library databases (on April 2023) for cohort studies assessing the association between circulating 25(OH)D concentrations and OS in patients with advanced pancreatic cancers. Medical Subject Headings including “Pancreatic Neoplasms” and “Vitamin D” were used to choose qualified studies, and these were further combined with keyword searches in titles and abstracts. Additionally, the references cited in all selected studies and published…\n\nStudy selection\nA flowchart of the study retrieval process is shown in Fig. 1. A total of 2166 potential studies were identified from the initial search of the previously mentioned databases, of which 538 were duplicates. After removing duplicate records and screening the titles and abstracts, 846 records remained. The full-text documents of these records were assessed, resulting in the exclusion of `├── BoldNode
│   full_match: `__839 records__`
│   inner_content: `839 records`
│   children:
│   ├── TextNode
│   │   full_match: `839 records`
│   │   inner_content: `839 records`├── TextNode
│   full_match: `. The exclusion criteria were as follows: (1) review articles (n = 445); (2) animal experiments (n…\n\nDiscussion\nThis meta-analysis is the first to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer and to assess the potential prognostic value of 25(OH)D. Our results supported the notion that a positive correlation existed between 25(OH)D and OS in patients with pancreatic cancer, which was consistent with our hypothesis.\n\nPancreatic cancer is a prevalent disease characterized by a low survival rate, primarily because it is often detected at advanced stages, …\n\nConclusion\nIn conclusion, our study indicated that 25(OH)D concentrations were positively correlated with OS, which may provide useful prognostic information for advanced pancreatic cancer patients. However, more studies are needed to validate this finding, and the mechanism behind the observation should be evaluated in further studies…`
│   inner_content: `. The exclusion criteria were as follows: (1) review articles (n = 445); (2) animal experiments (n…\n\nDiscussion\nThis meta-analysis is the first to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer and to assess the potential prognostic value of 25(OH)D. Our results supported the notion that a positive correlation existed between 25(OH)D and OS in patients with pancreatic cancer, which was consistent with our hypothesis.\n\nPancreatic cancer is a prevalent disease characterized by a low survival rate, primarily because it is often detected at advanced stages, …\n\nConclusion\nIn conclusion, our study indicated that 25(OH)D concentrations were positively correlated with OS, which may provide useful prognostic information for advanced pancreatic cancer patients. However, more studies are needed to validate this finding, and the mechanism behind the observation should be evaluated in further studies…`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!!Some titles of references`
│   inner_content: `Some titles of references`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Some titles of references`
│   │   inner_content: `Some titles of references`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vitamin D and pancreatic cancer`
│   inner_content: `Vitamin D and pancreatic cancer`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D and pancreatic cancer`
│   │   inner_content: `Vitamin D and pancreatic cancer`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications`
│   inner_content: `Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications`
│   │   inner_content: `Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vitamin D for cancer prevention: global perspective`
│   inner_content: `Vitamin D for cancer prevention: global perspective`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D for cancer prevention: global perspective`
│   │   inner_content: `Vitamin D for cancer prevention: global perspective`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number`
│   inner_content: `Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number`
│   │   inner_content: `Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*The vitamin D system is deregulated in pancreatic diseases`
│   inner_content: `The vitamin D system is deregulated in pancreatic diseases`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `The vitamin D system is deregulated in pancreatic diseases`
│   │   inner_content: `The vitamin D system is deregulated in pancreatic diseases`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis`
│   inner_content: `Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis`
│   │   inner_content: `Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study`
│   inner_content: `Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study`
│   │   inner_content: `Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*The vitamin D dose response in obesity`
│   inner_content: `The vitamin D dose response in obesity`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `The vitamin D dose response in obesity`
│   │   inner_content: `The vitamin D dose response in obesity`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*High prevalence of vitamin D deficiency in urban health checkup population`
│   inner_content: `High prevalence of vitamin D deficiency in urban health checkup population`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `High prevalence of vitamin D deficiency in urban health checkup population`
│   │   inner_content: `High prevalence of vitamin D deficiency in urban health checkup population`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vitamin D, parathyroid hormone, and cardiovascular events among older adults`
│   inner_content: `Vitamin D, parathyroid hormone, and cardiovascular events among older adults`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D, parathyroid hormone, and cardiovascular events among older adults`
│   │   inner_content: `Vitamin D, parathyroid hormone, and cardiovascular events among older adults`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in t 47d breast cancer cells`
│   inner_content: `Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in t 47d breast cancer cells`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in t 47d breast cancer cells`
│   │   inner_content: `Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in t 47d breast cancer cells`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression`
│   inner_content: `Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression`
│   │   inner_content: `Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease`
│   inner_content: `Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease`
│   │   inner_content: `Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Current epidemiology of pancreatic cancer: challenges and opportunities`
│   inner_content: `Current epidemiology of pancreatic cancer: challenges and opportunities`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Current epidemiology of pancreatic cancer: challenges and opportunities`
│   │   inner_content: `Current epidemiology of pancreatic cancer: challenges and opportunities`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Pancreatic cancer: a review of epidemiology, trend, and risk factors`
│   inner_content: `Pancreatic cancer: a review of epidemiology, trend, and risk factors`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Pancreatic cancer: a review of epidemiology, trend, and risk factors`
│   │   inner_content: `Pancreatic cancer: a review of epidemiology, trend, and risk factors`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Pancreatic cancer: a review of current treatment and novel therapies`
│   inner_content: `Pancreatic cancer: a review of current treatment and novel therapies`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Pancreatic cancer: a review of current treatment and novel therapies`
│   │   inner_content: `Pancreatic cancer: a review of current treatment and novel therapies`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vitamin D binding protein and bone health`
│   inner_content: `Vitamin D binding protein and bone health`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D binding protein and bone health`
│   │   inner_content: `Vitamin D binding protein and bone health`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Sex differences in vitamin D metabolism, serum levels and action`
│   inner_content: `Sex differences in vitamin D metabolism, serum levels and action`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Sex differences in vitamin D metabolism, serum levels and action`
│   │   inner_content: `Sex differences in vitamin D metabolism, serum levels and action`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Calcipotriol targets lrp6 to inhibit wnt signaling in pancreatic cancer`
│   inner_content: `Calcipotriol targets lrp6 to inhibit wnt signaling in pancreatic cancer`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Calcipotriol targets lrp6 to inhibit wnt signaling in pancreatic cancer`
│   │   inner_content: `Calcipotriol targets lrp6 to inhibit wnt signaling in pancreatic cancer`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Activation of vitamin D receptor signaling downregulates the expression of nuclear foxm1 protein and suppresses pancreatic cancer cell stemness`
│   inner_content: `Activation of vitamin D receptor signaling downregulates the expression of nuclear foxm1 protein and suppresses pancreatic cancer cell stemness`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Activation of vitamin D receptor signaling downregulates the expression of nuclear foxm1 protein and suppresses pancreatic cancer cell stemness`
│   │   inner_content: `Activation of vitamin D receptor signaling downregulates the expression of nuclear foxm1 protein and suppresses pancreatic cancer cell stemness`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Vitamin D for the prevention and treatment of pancreatic cancer`
│   inner_content: `Vitamin D for the prevention and treatment of pancreatic cancer`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D for the prevention and treatment of pancreatic cancer`
│   │   inner_content: `Vitamin D for the prevention and treatment of pancreatic cancer`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival`
│   inner_content: `Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival`
│   │   inner_content: `Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!40% less likely to die of Pancreatic Cancer if high vitamin D - meta-analyis Jan 2024`
│   inner_content: `40% less likely to die of Pancreatic Cancer if high vitamin D - meta-analyis Jan 2024`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `40% less likely to die of Pancreatic Cancer if high vitamin D - meta-analyis Jan 2024`
│   │   inner_content: `40% less likely to die of Pancreatic Cancer if high vitamin D - meta-analyis Jan 2024`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies__`
│   inner_content: `The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies`
│   children:
│   ├── TextNode
│   │   full_match: `The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies`
│   │   inner_content: `The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies`├── TextNode
│   full_match: `\nEur J Nutr. 2024 Jan 3. doi: `
│   inner_content: `\nEur J Nutr. 2024 Jan 3. doi: `├── LinkNode
│   full_match: `[10.1007/s00394-023-03302-w]`
│   inner_content: `10.1007/s00394-023-03302-w`
│   url: `10.1007/s00394-023-03302-w`
│   children:
│   ├── TextNode
│   │   full_match: `10.1007/s00394-023-03302-w`
│   │   inner_content: `10.1007/s00394-023-03302-w`├── TextNode
│   full_match: ` PDF behind paywall\nYajing Shen 1 2, Junfen Xia 3, Chuncheng Yi 1 2, Tiandong Li 1 2, Peng Wang 1 2, Liping Dai 2 4, Jianxiang Shi 2 4, Keyan Wang 2 4, Changqing Sun 1 5, Hua Ye 6 7\n\nPurpose: The relationship between circulating 25-hydroxyvitamin D `
│   inner_content: ` PDF behind paywall\nYajing Shen 1 2, Junfen Xia 3, Chuncheng Yi 1 2, Tiandong Li 1 2, Peng Wang 1 2, Liping Dai 2 4, Jianxiang Shi 2 4, Keyan Wang 2 4, Changqing Sun 1 5, Hua Ye 6 7\n\nPurpose: The relationship between circulating 25-hydroxyvitamin D `├── LinkNode
│   full_match: `[25(OH)D]`
│   inner_content: `25(OH)D`
│   url: `25(OH)D`
│   children:
│   ├── TextNode
│   │   full_match: `25(OH)D`
│   │   inner_content: `25(OH)D`├── TextNode
│   full_match: ` and pancreatic cancer has been well studied but remains unclear. The purpose of this study was to elucidate the association between circulating 25(OH)D and pancreatic cancer by using a meta-analytic approach.\n\nMethods: PubMed, Embase, and Wed of Science databases were searched through October 15, 2022. A random or fixed-effects model was used to estimate the pooled odds ratio (OR), risk ratio (RR), hazard ratio (HR) and their 95% confidence intervals (CIs).\n\nResults: A total of 16 studies including 529,917 participants met the inclusion criteria, of which 10 reported incidence and 6 reported mortality. For the highest versus lowest categories of circulating 25(OH)D, the pooled OR of pancreatic cancer incidence in case-control studies was 0.98 (95% CI 0.69-1.27), and the pooled HRs of pancreatic cancer mortality in cohort and case-control studies were `
│   inner_content: ` and pancreatic cancer has been well studied but remains unclear. The purpose of this study was to elucidate the association between circulating 25(OH)D and pancreatic cancer by using a meta-analytic approach.\n\nMethods: PubMed, Embase, and Wed of Science databases were searched through October 15, 2022. A random or fixed-effects model was used to estimate the pooled odds ratio (OR), risk ratio (RR), hazard ratio (HR) and their 95% confidence intervals (CIs).\n\nResults: A total of 16 studies including 529,917 participants met the inclusion criteria, of which 10 reported incidence and 6 reported mortality. For the highest versus lowest categories of circulating 25(OH)D, the pooled OR of pancreatic cancer incidence in case-control studies was 0.98 (95% CI 0.69-1.27), and the pooled HRs of pancreatic cancer mortality in cohort and case-control studies were `├── BoldNode
│   full_match: `__0.64__`
│   inner_content: `0.64`
│   children:
│   ├── TextNode
│   │   full_match: `0.64`
│   │   inner_content: `0.64`├── TextNode
│   full_match: ` (95% CI 0.45-0.82) and 0.78 (95% CI 0.62-0.95), respectively. The leave-one-out sensitivity analyses found no outliers and Galbraith plots indicated no substantial heterogeneity.\n\nConclusion: Evidence from this meta-analysis suggested that high circulating 25(OH)D levels may be associated with decreased mortality but not incidence of pancreatic cancer. Our findings may provide some clues for the treatment of pancreatic cancer and remind us to be cautious about widespread vitamin D supplementation for the prevention of pancreatic cancer.\n`
│   inner_content: ` (95% CI 0.45-0.82) and 0.78 (95% CI 0.62-0.95), respectively. The leave-one-out sensitivity analyses found no outliers and Galbraith plots indicated no substantial heterogeneity.\n\nConclusion: Evidence from this meta-analysis suggested that high circulating 25(OH)D levels may be associated with decreased mortality but not incidence of pancreatic cancer. Our findings may provide some clues for the treatment of pancreatic cancer and remind us to be cautious about widespread vitamin D supplementation for the prevention of pancreatic cancer.\n`├── HeadingNode
│   full_match: `!!!!!95 References`
│   inner_content: `95 References`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `95 References`
│   │   inner_content: `95 References`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed`
│   inner_content: `Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed`
│   │   inner_content: `Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48. https://doi.org/10.3322/caac.21763 - DOI - PubMed`
│   inner_content: `Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48. https://doi.org/10.3322/caac.21763 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48. https://doi.org/10.3322/caac.21763 - DOI - PubMed`
│   │   inner_content: `Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48. https://doi.org/10.3322/caac.21763 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#You L, Lv Z, Li C, Ye W, Zhou Y, Jin J, Han Q (2021) Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019. ESMO Open 6:100255. https://doi.org/10.1016/j.esmoop.2021.100255 - DOI - PubMed - PMC`
│   inner_content: `You L, Lv Z, Li C, Ye W, Zhou Y, Jin J, Han Q (2021) Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019. ESMO Open 6:100255. https://doi.org/10.1016/j.esmoop.2021.100255 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `You L, Lv Z, Li C, Ye W, Zhou Y, Jin J, Han Q (2021) Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019. ESMO Open 6:100255. https://doi.org/10.1016/j.esmoop.2021.100255 - DOI - PubMed - PMC`
│   │   inner_content: `You L, Lv Z, Li C, Ye W, Zhou Y, Jin J, Han Q (2021) Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019. ESMO Open 6:100255. https://doi.org/10.1016/j.esmoop.2021.100255 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010) Preoperative/neoadjuvant therapy in__ pancreatic cancer__: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267. https://doi.org/10.1371/journal.pmed.1000267 - DOI - PubMed - PMC`
│   inner_content: `Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010) Preoperative/neoadjuvant therapy in__ pancreatic cancer__: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267. https://doi.org/10.1371/journal.pmed.1000267 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010) Preoperative/neoadjuvant therapy in`
│   │   inner_content: `Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010) Preoperative/neoadjuvant therapy in`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267. https://doi.org/10.1371/journal.pmed.1000267 - DOI - PubMed - PMC`
│   │   inner_content: `: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267. https://doi.org/10.1371/journal.pmed.1000267 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005 - DOI - PubMed`
│   inner_content: `Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005 - DOI - PubMed`
│   │   inner_content: `Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Tempero MA (2019) NCCN guidelines updates:__ pancreatic cancer__. J Natl Compr Canc Netw 17:603–605. https://doi.org/10.6004/jnccn.2019.5007 - DOI - PubMed`
│   inner_content: `Tempero MA (2019) NCCN guidelines updates:__ pancreatic cancer__. J Natl Compr Canc Netw 17:603–605. https://doi.org/10.6004/jnccn.2019.5007 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Tempero MA (2019) NCCN guidelines updates:`
│   │   inner_content: `Tempero MA (2019) NCCN guidelines updates:`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `. J Natl Compr Canc Netw 17:603–605. https://doi.org/10.6004/jnccn.2019.5007 - DOI - PubMed`
│   │   inner_content: `. J Natl Compr Canc Netw 17:603–605. https://doi.org/10.6004/jnccn.2019.5007 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Clinton SK, Giovannucci EL, Hursting SD (2020) The World Cancer Research Fund/American Institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr 150:663–671. https://doi.org/10.1093/jn/nxz268 - DOI - PubMed`
│   inner_content: `Clinton SK, Giovannucci EL, Hursting SD (2020) The World Cancer Research Fund/American Institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr 150:663–671. https://doi.org/10.1093/jn/nxz268 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Clinton SK, Giovannucci EL, Hursting SD (2020) The World Cancer Research Fund/American Institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr 150:663–671. https://doi.org/10.1093/jn/nxz268 - DOI - PubMed`
│   │   inner_content: `Clinton SK, Giovannucci EL, Hursting SD (2020) The World Cancer Research Fund/American Institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr 150:663–671. https://doi.org/10.1093/jn/nxz268 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Qin X, Chen J, Jia G, Yang Z (2023) Dietary factors and__ pancreatic cancer__ risk: an umbrella review of meta-analyses of prospective observational studies. Adv Nutr 14:451–464. https://doi.org/10.1016/j.advnut.2023.02.004 - DOI - PubMed - PMC`
│   inner_content: `Qin X, Chen J, Jia G, Yang Z (2023) Dietary factors and__ pancreatic cancer__ risk: an umbrella review of meta-analyses of prospective observational studies. Adv Nutr 14:451–464. https://doi.org/10.1016/j.advnut.2023.02.004 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Qin X, Chen J, Jia G, Yang Z (2023) Dietary factors and`
│   │   inner_content: `Qin X, Chen J, Jia G, Yang Z (2023) Dietary factors and`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` risk: an umbrella review of meta-analyses of prospective observational studies. Adv Nutr 14:451–464. https://doi.org/10.1016/j.advnut.2023.02.004 - DOI - PubMed - PMC`
│   │   inner_content: ` risk: an umbrella review of meta-analyses of prospective observational studies. Adv Nutr 14:451–464. https://doi.org/10.1016/j.advnut.2023.02.004 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S et al (1993) A cohort study of smoking, alcohol consumption, and dietary factors for__ pancreatic cancer__ (United States). Cancer Causes Control 4:477–482. https://doi.org/10.1007/bf00050867 - DOI - PubMed`
│   inner_content: `Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S et al (1993) A cohort study of smoking, alcohol consumption, and dietary factors for__ pancreatic cancer__ (United States). Cancer Causes Control 4:477–482. https://doi.org/10.1007/bf00050867 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S et al (1993) A cohort study of smoking, alcohol consumption, and dietary factors for`
│   │   inner_content: `Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S et al (1993) A cohort study of smoking, alcohol consumption, and dietary factors for`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` (United States). Cancer Causes Control 4:477–482. https://doi.org/10.1007/bf00050867 - DOI - PubMed`
│   │   inner_content: ` (United States). Cancer Causes Control 4:477–482. https://doi.org/10.1007/bf00050867 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Peila R, Coday M, Crane TE, Saquib N, Shadyab AH, Tabung FK, Zhang X et al (2022) Healthy lifestyle index and risk of__ pancreatic cancer__ in the women’s health initiative. Cancer Causes Control 33:737–747. https://doi.org/10.1007/s10552-022-01558-x - DOI - PubMed - PMC`
│   inner_content: `Peila R, Coday M, Crane TE, Saquib N, Shadyab AH, Tabung FK, Zhang X et al (2022) Healthy lifestyle index and risk of__ pancreatic cancer__ in the women’s health initiative. Cancer Causes Control 33:737–747. https://doi.org/10.1007/s10552-022-01558-x - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Peila R, Coday M, Crane TE, Saquib N, Shadyab AH, Tabung FK, Zhang X et al (2022) Healthy lifestyle index and risk of`
│   │   inner_content: `Peila R, Coday M, Crane TE, Saquib N, Shadyab AH, Tabung FK, Zhang X et al (2022) Healthy lifestyle index and risk of`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` in the women’s health initiative. Cancer Causes Control 33:737–747. https://doi.org/10.1007/s10552-022-01558-x - DOI - PubMed - PMC`
│   │   inner_content: ` in the women’s health initiative. Cancer Causes Control 33:737–747. https://doi.org/10.1007/s10552-022-01558-x - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2003) Dietary meat, dairy products, fat, and cholesterol and__ pancreatic cancer__ risk in a prospective study. Am J Epidemiol 157:1115–1125. https://doi.org/10.1093/aje/kwg098 - DOI - PubMed`
│   inner_content: `Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2003) Dietary meat, dairy products, fat, and cholesterol and__ pancreatic cancer__ risk in a prospective study. Am J Epidemiol 157:1115–1125. https://doi.org/10.1093/aje/kwg098 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2003) Dietary meat, dairy products, fat, and cholesterol and`
│   │   inner_content: `Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2003) Dietary meat, dairy products, fat, and cholesterol and`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` risk in a prospective study. Am J Epidemiol 157:1115–1125. https://doi.org/10.1093/aje/kwg098 - DOI - PubMed`
│   │   inner_content: ` risk in a prospective study. Am J Epidemiol 157:1115–1125. https://doi.org/10.1093/aje/kwg098 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Chatterjee R, Fuss P, Vickery EM, LeBlanc ES, Sheehan PR, Lewis MR, Dolor RJ et al (2021) __vitamin__ D supplementation for prevention of cancer: the D2d cancer outcomes (D2dCA) ancillary study. J Clin Endocrinol Metab 106:2767–2778. https://doi.org/10.1210/clinem/dgab153 - DOI - PubMed - PMC`
│   inner_content: `Chatterjee R, Fuss P, Vickery EM, LeBlanc ES, Sheehan PR, Lewis MR, Dolor RJ et al (2021) __vitamin__ D supplementation for prevention of cancer: the D2d cancer outcomes (D2dCA) ancillary study. J Clin Endocrinol Metab 106:2767–2778. https://doi.org/10.1210/clinem/dgab153 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chatterjee R, Fuss P, Vickery EM, LeBlanc ES, Sheehan PR, Lewis MR, Dolor RJ et al (2021) `
│   │   inner_content: `Chatterjee R, Fuss P, Vickery EM, LeBlanc ES, Sheehan PR, Lewis MR, Dolor RJ et al (2021) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D supplementation for prevention of cancer: the D2d cancer outcomes (D2dCA) ancillary study. J Clin Endocrinol Metab 106:2767–2778. https://doi.org/10.1210/clinem/dgab153 - DOI - PubMed - PMC`
│   │   inner_content: ` D supplementation for prevention of cancer: the D2d cancer outcomes (D2dCA) ancillary study. J Clin Endocrinol Metab 106:2767–2778. https://doi.org/10.1210/clinem/dgab153 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Haykal T, Samji V, Zayed Y, Gakhal I, Dhillon H, Kheiri B, Kerbage J et al (2019) The role of __vitamin__ D supplementation for primary prevention of cancer: meta-analysis of randomized controlled trials. J Community Hosp Internal Med Persp 9:480–488. https://doi.org/10.1080/20009666.2019.1701839 - DOI`
│   inner_content: `Haykal T, Samji V, Zayed Y, Gakhal I, Dhillon H, Kheiri B, Kerbage J et al (2019) The role of __vitamin__ D supplementation for primary prevention of cancer: meta-analysis of randomized controlled trials. J Community Hosp Internal Med Persp 9:480–488. https://doi.org/10.1080/20009666.2019.1701839 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Haykal T, Samji V, Zayed Y, Gakhal I, Dhillon H, Kheiri B, Kerbage J et al (2019) The role of `
│   │   inner_content: `Haykal T, Samji V, Zayed Y, Gakhal I, Dhillon H, Kheiri B, Kerbage J et al (2019) The role of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D supplementation for primary prevention of cancer: meta-analysis of randomized controlled trials. J Community Hosp Internal Med Persp 9:480–488. https://doi.org/10.1080/20009666.2019.1701839 - DOI`
│   │   inner_content: ` D supplementation for primary prevention of cancer: meta-analysis of randomized controlled trials. J Community Hosp Internal Med Persp 9:480–488. https://doi.org/10.1080/20009666.2019.1701839 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Reid IR, Bolland MJ, Grey A (2014) Effects of __vitamin__ D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146–155. https://doi.org/10.1016/s0140-6736(13)61647-5 - DOI - PubMed`
│   inner_content: `Reid IR, Bolland MJ, Grey A (2014) Effects of __vitamin__ D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146–155. https://doi.org/10.1016/s0140-6736(13)61647-5 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Reid IR, Bolland MJ, Grey A (2014) Effects of `
│   │   inner_content: `Reid IR, Bolland MJ, Grey A (2014) Effects of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146–155. https://doi.org/10.1016/s0140-6736(13)61647-5 - DOI - PubMed`
│   │   inner_content: ` D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146–155. https://doi.org/10.1016/s0140-6736(13)61647-5 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Vanhevel J, Verlinden L, Doms S, Wildiers H, Verstuyf A (2022) The role of __vitamin__ D in breast cancer risk and progression. Endocr Relat Cancer 29:R33-r55. https://doi.org/10.1530/erc-21-0182 - DOI - PubMed`
│   inner_content: `Vanhevel J, Verlinden L, Doms S, Wildiers H, Verstuyf A (2022) The role of __vitamin__ D in breast cancer risk and progression. Endocr Relat Cancer 29:R33-r55. https://doi.org/10.1530/erc-21-0182 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vanhevel J, Verlinden L, Doms S, Wildiers H, Verstuyf A (2022) The role of `
│   │   inner_content: `Vanhevel J, Verlinden L, Doms S, Wildiers H, Verstuyf A (2022) The role of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D in breast cancer risk and progression. Endocr Relat Cancer 29:R33-r55. https://doi.org/10.1530/erc-21-0182 - DOI - PubMed`
│   │   inner_content: ` D in breast cancer risk and progression. Endocr Relat Cancer 29:R33-r55. https://doi.org/10.1530/erc-21-0182 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Kim H, Lipsyc-Sharf M, Zong X, Wang X, Hur J, Song M, Wang M et al (2021) Total __vitamin__ D intake and risks of early-onset colorectal cancer and precursors. Gastroenterology 161:1208-1217.e9. https://doi.org/10.1053/j.gastro.2021.07.002 - DOI - PubMed`
│   inner_content: `Kim H, Lipsyc-Sharf M, Zong X, Wang X, Hur J, Song M, Wang M et al (2021) Total __vitamin__ D intake and risks of early-onset colorectal cancer and precursors. Gastroenterology 161:1208-1217.e9. https://doi.org/10.1053/j.gastro.2021.07.002 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kim H, Lipsyc-Sharf M, Zong X, Wang X, Hur J, Song M, Wang M et al (2021) Total `
│   │   inner_content: `Kim H, Lipsyc-Sharf M, Zong X, Wang X, Hur J, Song M, Wang M et al (2021) Total `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D intake and risks of early-onset colorectal cancer and precursors. Gastroenterology 161:1208-1217.e9. https://doi.org/10.1053/j.gastro.2021.07.002 - DOI - PubMed`
│   │   inner_content: ` D intake and risks of early-onset colorectal cancer and precursors. Gastroenterology 161:1208-1217.e9. https://doi.org/10.1053/j.gastro.2021.07.002 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Kanaan Y, Copeland RL (2022) The link between __vitamin__ D and prostate cancer. Nat Rev Cancer 22:435. https://doi.org/10.1038/s41568-022-00493-y - DOI - PubMed`
│   inner_content: `Kanaan Y, Copeland RL (2022) The link between __vitamin__ D and prostate cancer. Nat Rev Cancer 22:435. https://doi.org/10.1038/s41568-022-00493-y - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kanaan Y, Copeland RL (2022) The link between `
│   │   inner_content: `Kanaan Y, Copeland RL (2022) The link between `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and prostate cancer. Nat Rev Cancer 22:435. https://doi.org/10.1038/s41568-022-00493-y - DOI - PubMed`
│   │   inner_content: ` D and prostate cancer. Nat Rev Cancer 22:435. https://doi.org/10.1038/s41568-022-00493-y - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Jones G (2013) Extrarenal __vitamin__ D activation and interactions between __vitamin__ D2, __vitamin__ D3, and __vitamin__ D analogs. Annu Rev Nutr 33:23–44. https://doi.org/10.1146/annurev-nutr-071812-161203 - DOI - PubMed`
│   inner_content: `Jones G (2013) Extrarenal __vitamin__ D activation and interactions between __vitamin__ D2, __vitamin__ D3, and __vitamin__ D analogs. Annu Rev Nutr 33:23–44. https://doi.org/10.1146/annurev-nutr-071812-161203 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Jones G (2013) Extrarenal `
│   │   inner_content: `Jones G (2013) Extrarenal `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D activation and interactions between `
│   │   inner_content: ` D activation and interactions between `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D2, `
│   │   inner_content: ` D2, `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3, and `
│   │   inner_content: ` D3, and `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D analogs. Annu Rev Nutr 33:23–44. https://doi.org/10.1146/annurev-nutr-071812-161203 - DOI - PubMed`
│   │   inner_content: ` D analogs. Annu Rev Nutr 33:23–44. https://doi.org/10.1146/annurev-nutr-071812-161203 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Wilson LR, Tripkovic L, Hart KH, Lanham-New SA (2017) __vitamin__ D deficiency as a public health issue: using __vitamin__ D2 or __vitamin__ D3 in future fortification strategies. Proc Nutr Soc 76:392–399. https://doi.org/10.1017/s0029665117000349 - DOI - PubMed`
│   inner_content: `Wilson LR, Tripkovic L, Hart KH, Lanham-New SA (2017) __vitamin__ D deficiency as a public health issue: using __vitamin__ D2 or __vitamin__ D3 in future fortification strategies. Proc Nutr Soc 76:392–399. https://doi.org/10.1017/s0029665117000349 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wilson LR, Tripkovic L, Hart KH, Lanham-New SA (2017) `
│   │   inner_content: `Wilson LR, Tripkovic L, Hart KH, Lanham-New SA (2017) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency as a public health issue: using `
│   │   inner_content: ` D deficiency as a public health issue: using `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D2 or `
│   │   inner_content: ` D2 or `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 in future fortification strategies. Proc Nutr Soc 76:392–399. https://doi.org/10.1017/s0029665117000349 - DOI - PubMed`
│   │   inner_content: ` D3 in future fortification strategies. Proc Nutr Soc 76:392–399. https://doi.org/10.1017/s0029665117000349 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Holick MF (2004) __vitamin__ D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371. https://doi.org/10.1093/ajcn/79.3.362 - DOI - PubMed`
│   inner_content: `Holick MF (2004) __vitamin__ D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371. https://doi.org/10.1093/ajcn/79.3.362 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Holick MF (2004) `
│   │   inner_content: `Holick MF (2004) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371. https://doi.org/10.1093/ajcn/79.3.362 - DOI - PubMed`
│   │   inner_content: ` D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371. https://doi.org/10.1093/ajcn/79.3.362 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Green J (1951) Studies on the analysis of __vitamin__s D. 4. Studies on the irradiation of ergosterol and 7-dehydrocholesterol and the analysis of the products for calciferol, __vitamin__ D3, and component sterols. Biochem J 49:232–243. https://doi.org/10.1042/bj0490232 - DOI - PubMed - PMC`
│   inner_content: `Green J (1951) Studies on the analysis of __vitamin__s D. 4. Studies on the irradiation of ergosterol and 7-dehydrocholesterol and the analysis of the products for calciferol, __vitamin__ D3, and component sterols. Biochem J 49:232–243. https://doi.org/10.1042/bj0490232 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Green J (1951) Studies on the analysis of `
│   │   inner_content: `Green J (1951) Studies on the analysis of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: `s D. 4. Studies on the irradiation of ergosterol and 7-dehydrocholesterol and the analysis of the products for calciferol, `
│   │   inner_content: `s D. 4. Studies on the irradiation of ergosterol and 7-dehydrocholesterol and the analysis of the products for calciferol, `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3, and component sterols. Biochem J 49:232–243. https://doi.org/10.1042/bj0490232 - DOI - PubMed - PMC`
│   │   inner_content: ` D3, and component sterols. Biochem J 49:232–243. https://doi.org/10.1042/bj0490232 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bikle DD (2014) __vitamin__ D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329. https://doi.org/10.1016/j.chembiol.2013.12.016 - DOI - PubMed - PMC`
│   inner_content: `Bikle DD (2014) __vitamin__ D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329. https://doi.org/10.1016/j.chembiol.2013.12.016 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bikle DD (2014) `
│   │   inner_content: `Bikle DD (2014) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329. https://doi.org/10.1016/j.chembiol.2013.12.016 - DOI - PubMed - PMC`
│   │   inner_content: ` D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329. https://doi.org/10.1016/j.chembiol.2013.12.016 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG (2014) __vitamin__ D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2:298–306. https://doi.org/10.1016/s2213-8587(13)70200-6 - DOI - PubMed`
│   inner_content: `Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG (2014) __vitamin__ D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2:298–306. https://doi.org/10.1016/s2213-8587(13)70200-6 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG (2014) `
│   │   inner_content: `Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG (2014) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2:298–306. https://doi.org/10.1016/s2213-8587(13)70200-6 - DOI - PubMed`
│   │   inner_content: ` D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2:298–306. https://doi.org/10.1016/s2213-8587(13)70200-6 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD et al (2013) Causal relationship between obesity and __vitamin__ D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383. https://doi.org/10.1371/journal.pmed.1001383 - DOI - PubMed - PMC`
│   inner_content: `Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD et al (2013) Causal relationship between obesity and __vitamin__ D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383. https://doi.org/10.1371/journal.pmed.1001383 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD et al (2013) Causal relationship between obesity and `
│   │   inner_content: `Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD et al (2013) Causal relationship between obesity and `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383. https://doi.org/10.1371/journal.pmed.1001383 - DOI - PubMed - PMC`
│   │   inner_content: ` D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383. https://doi.org/10.1371/journal.pmed.1001383 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of __vitamin__ D in obesity. Am J Clin Nutr 72:690–693. https://doi.org/10.1093/ajcn/72.3.690 - DOI - PubMed`
│   inner_content: `Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of __vitamin__ D in obesity. Am J Clin Nutr 72:690–693. https://doi.org/10.1093/ajcn/72.3.690 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of `
│   │   inner_content: `Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D in obesity. Am J Clin Nutr 72:690–693. https://doi.org/10.1093/ajcn/72.3.690 - DOI - PubMed`
│   │   inner_content: ` D in obesity. Am J Clin Nutr 72:690–693. https://doi.org/10.1093/ajcn/72.3.690 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Savastano S, Barrea L, Savanelli MC, Nappi F, Di Somma C, Orio F, Colao A (2017) Low __vitamin__ D status and obesity: role of nutritionist. Rev Endocr Metab Disord 18:215–225. https://doi.org/10.1007/s11154-017-9410-7 - DOI - PubMed`
│   inner_content: `Savastano S, Barrea L, Savanelli MC, Nappi F, Di Somma C, Orio F, Colao A (2017) Low __vitamin__ D status and obesity: role of nutritionist. Rev Endocr Metab Disord 18:215–225. https://doi.org/10.1007/s11154-017-9410-7 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Savastano S, Barrea L, Savanelli MC, Nappi F, Di Somma C, Orio F, Colao A (2017) Low `
│   │   inner_content: `Savastano S, Barrea L, Savanelli MC, Nappi F, Di Somma C, Orio F, Colao A (2017) Low `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D status and obesity: role of nutritionist. Rev Endocr Metab Disord 18:215–225. https://doi.org/10.1007/s11154-017-9410-7 - DOI - PubMed`
│   │   inner_content: ` D status and obesity: role of nutritionist. Rev Endocr Metab Disord 18:215–225. https://doi.org/10.1007/s11154-017-9410-7 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Fernandes MR, Barreto WDRJ (2017) Association between physical activity and __vitamin__ D: a narrative literature review. Rev Assoc Med Bras (1993) 63:550–556. https://doi.org/10.1590/1806-9282.63.06.550 - DOI`
│   inner_content: `Fernandes MR, Barreto WDRJ (2017) Association between physical activity and __vitamin__ D: a narrative literature review. Rev Assoc Med Bras (1993) 63:550–556. https://doi.org/10.1590/1806-9282.63.06.550 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Fernandes MR, Barreto WDRJ (2017) Association between physical activity and `
│   │   inner_content: `Fernandes MR, Barreto WDRJ (2017) Association between physical activity and `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D: a narrative literature review. Rev Assoc Med Bras (1993) 63:550–556. https://doi.org/10.1590/1806-9282.63.06.550 - DOI`
│   │   inner_content: ` D: a narrative literature review. Rev Assoc Med Bras (1993) 63:550–556. https://doi.org/10.1590/1806-9282.63.06.550 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bicakli DH, Uslu R, Güney SC, Coker A (2020) The relationship between nutritional status, performance status, and survival among__ pancreatic cancer__ patients. Nutr Cancer 72:202–208. https://doi.org/10.1080/01635581.2019.1634217 - DOI - PubMed`
│   inner_content: `Bicakli DH, Uslu R, Güney SC, Coker A (2020) The relationship between nutritional status, performance status, and survival among__ pancreatic cancer__ patients. Nutr Cancer 72:202–208. https://doi.org/10.1080/01635581.2019.1634217 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bicakli DH, Uslu R, Güney SC, Coker A (2020) The relationship between nutritional status, performance status, and survival among`
│   │   inner_content: `Bicakli DH, Uslu R, Güney SC, Coker A (2020) The relationship between nutritional status, performance status, and survival among`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` patients. Nutr Cancer 72:202–208. https://doi.org/10.1080/01635581.2019.1634217 - DOI - PubMed`
│   │   inner_content: ` patients. Nutr Cancer 72:202–208. https://doi.org/10.1080/01635581.2019.1634217 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Kubiak J, Kamycheva E, Jorde R (2021) Tracking of serum 25-hydroxy__vitamin__ D during 21 years. Eur J Clin Nutr 75:1069–1076. https://doi.org/10.1038/s41430-020-00814-0 - DOI - PubMed`
│   inner_content: `Kubiak J, Kamycheva E, Jorde R (2021) Tracking of serum 25-hydroxy__vitamin__ D during 21 years. Eur J Clin Nutr 75:1069–1076. https://doi.org/10.1038/s41430-020-00814-0 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kubiak J, Kamycheva E, Jorde R (2021) Tracking of serum 25-hydroxy`
│   │   inner_content: `Kubiak J, Kamycheva E, Jorde R (2021) Tracking of serum 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D during 21 years. Eur J Clin Nutr 75:1069–1076. https://doi.org/10.1038/s41430-020-00814-0 - DOI - PubMed`
│   │   inner_content: ` D during 21 years. Eur J Clin Nutr 75:1069–1076. https://doi.org/10.1038/s41430-020-00814-0 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Borel P, Caillaud D, Cano NJ (2015) __vitamin__ D bioavailability: state of the art. Crit Rev Food Sci Nutr 55:1193–1205. https://doi.org/10.1080/10408398.2012.688897 - DOI - PubMed`
│   inner_content: `Borel P, Caillaud D, Cano NJ (2015) __vitamin__ D bioavailability: state of the art. Crit Rev Food Sci Nutr 55:1193–1205. https://doi.org/10.1080/10408398.2012.688897 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Borel P, Caillaud D, Cano NJ (2015) `
│   │   inner_content: `Borel P, Caillaud D, Cano NJ (2015) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D bioavailability: state of the art. Crit Rev Food Sci Nutr 55:1193–1205. https://doi.org/10.1080/10408398.2012.688897 - DOI - PubMed`
│   │   inner_content: ` D bioavailability: state of the art. Crit Rev Food Sci Nutr 55:1193–1205. https://doi.org/10.1080/10408398.2012.688897 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Stolzenberg-Solomon RZ (2009) __vitamin__ D and__ pancreatic cancer__. Ann Epidemiol 19:89–95. https://doi.org/10.1016/j.annepidem.2008.03.010 - DOI - PubMed`
│   inner_content: `Stolzenberg-Solomon RZ (2009) __vitamin__ D and__ pancreatic cancer__. Ann Epidemiol 19:89–95. https://doi.org/10.1016/j.annepidem.2008.03.010 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Stolzenberg-Solomon RZ (2009) `
│   │   inner_content: `Stolzenberg-Solomon RZ (2009) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and`
│   │   inner_content: ` D and`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `. Ann Epidemiol 19:89–95. https://doi.org/10.1016/j.annepidem.2008.03.010 - DOI - PubMed`
│   │   inner_content: `. Ann Epidemiol 19:89–95. https://doi.org/10.1016/j.annepidem.2008.03.010 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Sanchez GV, Weinstein SJ, Stolzenberg-Solomon RZ (2012) Is dietary fat, __vitamin__ D, or folate associated with__ pancreatic cancer__? Mol Carcinog 51:119–127. https://doi.org/10.1002/mc.20833 - DOI - PubMed - PMC`
│   inner_content: `Sanchez GV, Weinstein SJ, Stolzenberg-Solomon RZ (2012) Is dietary fat, __vitamin__ D, or folate associated with__ pancreatic cancer__? Mol Carcinog 51:119–127. https://doi.org/10.1002/mc.20833 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Sanchez GV, Weinstein SJ, Stolzenberg-Solomon RZ (2012) Is dietary fat, `
│   │   inner_content: `Sanchez GV, Weinstein SJ, Stolzenberg-Solomon RZ (2012) Is dietary fat, `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D, or folate associated with`
│   │   inner_content: ` D, or folate associated with`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `? Mol Carcinog 51:119–127. https://doi.org/10.1002/mc.20833 - DOI - PubMed - PMC`
│   │   inner_content: `? Mol Carcinog 51:119–127. https://doi.org/10.1002/mc.20833 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC (2010) Ultraviolet B irradiance and __vitamin__ D status are inversely associated with incidence rates of__ pancreatic cancer__ worldwide. Pancreas 39:669–674. https://doi.org/10.1097/MPA.0b013e3181ce654d - DOI - PubMed`
│   inner_content: `Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC (2010) Ultraviolet B irradiance and __vitamin__ D status are inversely associated with incidence rates of__ pancreatic cancer__ worldwide. Pancreas 39:669–674. https://doi.org/10.1097/MPA.0b013e3181ce654d - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC (2010) Ultraviolet B irradiance and `
│   │   inner_content: `Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC (2010) Ultraviolet B irradiance and `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D status are inversely associated with incidence rates of`
│   │   inner_content: ` D status are inversely associated with incidence rates of`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` worldwide. Pancreas 39:669–674. https://doi.org/10.1097/MPA.0b013e3181ce654d - DOI - PubMed`
│   │   inner_content: ` worldwide. Pancreas 39:669–674. https://doi.org/10.1097/MPA.0b013e3181ce654d - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted __vitamin__ D status and__ pancreatic cancer__ risk in two prospective cohort studies. Br J Cancer 102:1422–1427. https://doi.org/10.1038/sj.bjc.6605658 - DOI - PubMed - PMC`
│   inner_content: `Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted __vitamin__ D status and__ pancreatic cancer__ risk in two prospective cohort studies. Br J Cancer 102:1422–1427. https://doi.org/10.1038/sj.bjc.6605658 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted `
│   │   inner_content: `Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D status and`
│   │   inner_content: ` D status and`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` risk in two prospective cohort studies. Br J Cancer 102:1422–1427. https://doi.org/10.1038/sj.bjc.6605658 - DOI - PubMed - PMC`
│   │   inner_content: ` risk in two prospective cohort studies. Br J Cancer 102:1422–1427. https://doi.org/10.1038/sj.bjc.6605658 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (2006) Prospective study of predictors of __vitamin__ D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459. https://doi.org/10.1093/jnci/djj101 - DOI - PubMed`
│   inner_content: `Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (2006) Prospective study of predictors of __vitamin__ D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459. https://doi.org/10.1093/jnci/djj101 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (2006) Prospective study of predictors of `
│   │   inner_content: `Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (2006) Prospective study of predictors of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459. https://doi.org/10.1093/jnci/djj101 - DOI - PubMed`
│   │   inner_content: ` D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459. https://doi.org/10.1093/jnci/djj101 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, Ng K et al (2016) Prediagnostic plasma 25-hydroxy__vitamin__ D and__ pancreatic cancer__ survival. J Clin Oncol 34:2899–2905. https://doi.org/10.1200/jco.2015.66.3005 - DOI - PubMed - PMC`
│   inner_content: `Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, Ng K et al (2016) Prediagnostic plasma 25-hydroxy__vitamin__ D and__ pancreatic cancer__ survival. J Clin Oncol 34:2899–2905. https://doi.org/10.1200/jco.2015.66.3005 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, Ng K et al (2016) Prediagnostic plasma 25-hydroxy`
│   │   inner_content: `Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, Ng K et al (2016) Prediagnostic plasma 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and`
│   │   inner_content: ` D and`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` survival. J Clin Oncol 34:2899–2905. https://doi.org/10.1200/jco.2015.66.3005 - DOI - PubMed - PMC`
│   │   inner_content: ` survival. J Clin Oncol 34:2899–2905. https://doi.org/10.1200/jco.2015.66.3005 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP et al (2004)__ pancreatic cancer__ cells express 25-hydroxy__vitamin__ D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxy__vitamin__ D3. Carcinogenesis 25:1015–1026. https://doi.org/10.1093/carcin/bgh086 - DOI - PubMed`
│   inner_content: `Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP et al (2004)__ pancreatic cancer__ cells express 25-hydroxy__vitamin__ D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxy__vitamin__ D3. Carcinogenesis 25:1015–1026. https://doi.org/10.1093/carcin/bgh086 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP et al (2004)`
│   │   inner_content: `Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP et al (2004)`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` cells express 25-hydroxy`
│   │   inner_content: ` cells express 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxy`
│   │   inner_content: ` D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3. Carcinogenesis 25:1015–1026. https://doi.org/10.1093/carcin/bgh086 - DOI - PubMed`
│   │   inner_content: ` D3. Carcinogenesis 25:1015–1026. https://doi.org/10.1093/carcin/bgh086 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Pettersson F, Colston KW, Dalgleish AG (2000) Differential and antagonistic effects of 9-cis-retinoic acid and __vitamin__ D analogues on__ pancreatic cancer__ cells in vitro. Br J Cancer 83:239–245. https://doi.org/10.1054/bjoc.2000.1281 - DOI - PubMed - PMC`
│   inner_content: `Pettersson F, Colston KW, Dalgleish AG (2000) Differential and antagonistic effects of 9-cis-retinoic acid and __vitamin__ D analogues on__ pancreatic cancer__ cells in vitro. Br J Cancer 83:239–245. https://doi.org/10.1054/bjoc.2000.1281 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Pettersson F, Colston KW, Dalgleish AG (2000) Differential and antagonistic effects of 9-cis-retinoic acid and `
│   │   inner_content: `Pettersson F, Colston KW, Dalgleish AG (2000) Differential and antagonistic effects of 9-cis-retinoic acid and `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D analogues on`
│   │   inner_content: ` D analogues on`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` cells in vitro. Br J Cancer 83:239–245. https://doi.org/10.1054/bjoc.2000.1281 - DOI - PubMed - PMC`
│   │   inner_content: ` cells in vitro. Br J Cancer 83:239–245. https://doi.org/10.1054/bjoc.2000.1281 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T et al (1996) Inhibitory effect of 220-oxa-1,25-dihydroxy__vitamin__ D3 on the proliferation of__ pancreatic cancer__ cell lines. Gastroenterology 110:1605–1613. https://doi.org/10.1053/gast.1996.v110.pm8613068 - DOI - PubMed`
│   inner_content: `Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T et al (1996) Inhibitory effect of 220-oxa-1,25-dihydroxy__vitamin__ D3 on the proliferation of__ pancreatic cancer__ cell lines. Gastroenterology 110:1605–1613. https://doi.org/10.1053/gast.1996.v110.pm8613068 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T et al (1996) Inhibitory effect of 220-oxa-1,25-dihydroxy`
│   │   inner_content: `Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T et al (1996) Inhibitory effect of 220-oxa-1,25-dihydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 on the proliferation of`
│   │   inner_content: ` D3 on the proliferation of`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` cell lines. Gastroenterology 110:1605–1613. https://doi.org/10.1053/gast.1996.v110.pm8613068 - DOI - PubMed`
│   │   inner_content: ` cell lines. Gastroenterology 110:1605–1613. https://doi.org/10.1053/gast.1996.v110.pm8613068 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Colston KW, James SY, Ofori-Kuragu EA, Binderup L, Grant AG (1997) __vitamin__ D receptors and anti-proliferative effects of __vitamin__ D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 76:1017–1020. https://doi.org/10.1038/bjc.1997.501 - DOI - PubMed - PMC`
│   inner_content: `Colston KW, James SY, Ofori-Kuragu EA, Binderup L, Grant AG (1997) __vitamin__ D receptors and anti-proliferative effects of __vitamin__ D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 76:1017–1020. https://doi.org/10.1038/bjc.1997.501 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Colston KW, James SY, Ofori-Kuragu EA, Binderup L, Grant AG (1997) `
│   │   inner_content: `Colston KW, James SY, Ofori-Kuragu EA, Binderup L, Grant AG (1997) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D receptors and anti-proliferative effects of `
│   │   inner_content: ` D receptors and anti-proliferative effects of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 76:1017–1020. https://doi.org/10.1038/bjc.1997.501 - DOI - PubMed - PMC`
│   │   inner_content: ` D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 76:1017–1020. https://doi.org/10.1038/bjc.1997.501 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, Kampman E et al (2018) Circulating concentrations of __vitamin__ D in relation to__ pancreatic cancer__ risk in European populations. Int J Cancer 142:1189–1201. https://doi.org/10.1002/ijc.31146 - DOI - PubMed`
│   inner_content: `van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, Kampman E et al (2018) Circulating concentrations of __vitamin__ D in relation to__ pancreatic cancer__ risk in European populations. Int J Cancer 142:1189–1201. https://doi.org/10.1002/ijc.31146 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, Kampman E et al (2018) Circulating concentrations of `
│   │   inner_content: `van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, Kampman E et al (2018) Circulating concentrations of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D in relation to`
│   │   inner_content: ` D in relation to`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` risk in European populations. Int J Cancer 142:1189–1201. https://doi.org/10.1002/ijc.31146 - DOI - PubMed`
│   │   inner_content: ` risk in European populations. Int J Cancer 142:1189–1201. https://doi.org/10.1002/ijc.31146 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ et al (2010) Circulating 25-hydroxy__vitamin__ D and risk of__ pancreatic cancer__: cohort consortium __vitamin__ D pooling project of rarer cancers. Am J Epidemiol 172:81–93. https://doi.org/10.1093/aje/kwq120 - DOI - PubMed - PMC`
│   inner_content: `Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ et al (2010) Circulating 25-hydroxy__vitamin__ D and risk of__ pancreatic cancer__: cohort consortium __vitamin__ D pooling project of rarer cancers. Am J Epidemiol 172:81–93. https://doi.org/10.1093/aje/kwq120 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ et al (2010) Circulating 25-hydroxy`
│   │   inner_content: `Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ et al (2010) Circulating 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and risk of`
│   │   inner_content: ` D and risk of`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `: cohort consortium `
│   │   inner_content: `: cohort consortium `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D pooling project of rarer cancers. Am J Epidemiol 172:81–93. https://doi.org/10.1093/aje/kwq120 - DOI - PubMed - PMC`
│   │   inner_content: ` D pooling project of rarer cancers. Am J Epidemiol 172:81–93. https://doi.org/10.1093/aje/kwq120 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012) Impact of circulating __vitamin__ D binding protein levels on the association between 25-hydroxy__vitamin__ D and__ pancreatic cancer__ risk: a nested case-control study. Cancer Res 72:1190–1198. https://doi.org/10.1158/0008-5472.Can-11-2950 - DOI - PubMed - PMC`
│   inner_content: `Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012) Impact of circulating __vitamin__ D binding protein levels on the association between 25-hydroxy__vitamin__ D and__ pancreatic cancer__ risk: a nested case-control study. Cancer Res 72:1190–1198. https://doi.org/10.1158/0008-5472.Can-11-2950 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012) Impact of circulating `
│   │   inner_content: `Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012) Impact of circulating `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D binding protein levels on the association between 25-hydroxy`
│   │   inner_content: ` D binding protein levels on the association between 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and`
│   │   inner_content: ` D and`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` risk: a nested case-control study. Cancer Res 72:1190–1198. https://doi.org/10.1158/0008-5472.Can-11-2950 - DOI - PubMed - PMC`
│   │   inner_content: ` risk: a nested case-control study. Cancer Res 72:1190–1198. https://doi.org/10.1158/0008-5472.Can-11-2950 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D et al (2000) Meta-analysis of observational studies in epidemiology—ā proposal for reporting. Jama-J Am Med Assoc 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008 - DOI`
│   inner_content: `Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D et al (2000) Meta-analysis of observational studies in epidemiology—ā proposal for reporting. Jama-J Am Med Assoc 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D et al (2000) Meta-analysis of observational studies in epidemiology—ā proposal for reporting. Jama-J Am Med Assoc 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008 - DOI`
│   │   inner_content: `Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D et al (2000) Meta-analysis of observational studies in epidemiology—ā proposal for reporting. Jama-J Am Med Assoc 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71 - DOI - PubMed - PMC`
│   inner_content: `Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71 - DOI - PubMed - PMC`
│   │   inner_content: `Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD - DOI`
│   inner_content: `von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD - DOI`
│   │   inner_content: `von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z - DOI - PubMed`
│   inner_content: `Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z - DOI - PubMed`
│   │   inner_content: `Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Institute of Medicine Committee to Review Dietary Reference Intakes for __vitamin__ D, Calcium (2011) The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press (US) Copyright © 2011, National Academy of Sciences., Washington (DC)`
│   inner_content: `Institute of Medicine Committee to Review Dietary Reference Intakes for __vitamin__ D, Calcium (2011) The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press (US) Copyright © 2011, National Academy of Sciences., Washington (DC)`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Institute of Medicine Committee to Review Dietary Reference Intakes for `
│   │   inner_content: `Institute of Medicine Committee to Review Dietary Reference Intakes for `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D, Calcium (2011) The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press (US) Copyright © 2011, National Academy of Sciences., Washington (DC)`
│   │   inner_content: ` D, Calcium (2011) The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press (US) Copyright © 2011, National Academy of Sciences., Washington (DC)`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH et al (2011) Evaluation, treatment, and prevention of __vitamin__ D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930. https://doi.org/10.1210/jc.2011-0385 - DOI - PubMed`
│   inner_content: `Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH et al (2011) Evaluation, treatment, and prevention of __vitamin__ D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930. https://doi.org/10.1210/jc.2011-0385 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH et al (2011) Evaluation, treatment, and prevention of `
│   │   inner_content: `Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH et al (2011) Evaluation, treatment, and prevention of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930. https://doi.org/10.1210/jc.2011-0385 - DOI - PubMed`
│   │   inner_content: ` D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930. https://doi.org/10.1210/jc.2011-0385 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, Cooper C et al (2022) Role of __vitamin__ D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res 34:2603–2623. https://doi.org/10.1007/s40520-022-02279-6 - DOI - PubMed - PMC`
│   inner_content: `Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, Cooper C et al (2022) Role of __vitamin__ D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res 34:2603–2623. https://doi.org/10.1007/s40520-022-02279-6 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, Cooper C et al (2022) Role of `
│   │   inner_content: `Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, Cooper C et al (2022) Role of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res 34:2603–2623. https://doi.org/10.1007/s40520-022-02279-6 - DOI - PubMed - PMC`
│   │   inner_content: ` D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res 34:2603–2623. https://doi.org/10.1007/s40520-022-02279-6 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxy__vitamin__ D for multiple health outcomes. Am J Clin Nutr 84:18–28. https://doi.org/10.1093/ajcn/84.1.18 - DOI - PubMed`
│   inner_content: `Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxy__vitamin__ D for multiple health outcomes. Am J Clin Nutr 84:18–28. https://doi.org/10.1093/ajcn/84.1.18 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxy`
│   │   inner_content: `Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D for multiple health outcomes. Am J Clin Nutr 84:18–28. https://doi.org/10.1093/ajcn/84.1.18 - DOI - PubMed`
│   │   inner_content: ` D for multiple health outcomes. Am J Clin Nutr 84:18–28. https://doi.org/10.1093/ajcn/84.1.18 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139–145. https://doi.org/10.1016/j.cct.2015.09.002 - DOI - PubMed - PMC`
│   inner_content: `DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139–145. https://doi.org/10.1016/j.cct.2015.09.002 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139–145. https://doi.org/10.1016/j.cct.2015.09.002 - DOI - PubMed - PMC`
│   │   inner_content: `DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139–145. https://doi.org/10.1016/j.cct.2015.09.002 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15:1237–48. https://doi.org/10.1002/(SICI)1097-0258(19960630)15:12&lt;1237::AID-SIM301&gt;3.0.CO;2-N - DOI - PubMed`
│   inner_content: `DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15:1237–48. https://doi.org/10.1002/(SICI)1097-0258(19960630)15:12&lt;1237::AID-SIM301&gt;3.0.CO;2-N - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15:1237–48. https://doi.org/10.1002/(SICI)1097-0258(19960630)15:12&lt;1237::AID-SIM301&gt;3.0.CO;2-N - DOI - PubMed`
│   │   inner_content: `DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15:1237–48. https://doi.org/10.1002/(SICI)1097-0258(19960630)15:12&lt;1237::AID-SIM301&gt;3.0.CO;2-N - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2 - DOI - PubMed`
│   inner_content: `DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2 - DOI - PubMed`
│   │   inner_content: `DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557 - DOI - PubMed - PMC`
│   inner_content: `Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557 - DOI - PubMed - PMC`
│   │   inner_content: `Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Jeon SM, Shin EA (2018) Exploring __vitamin__ D metabolism and function in cancer. Exp Mol Med 50:1–14. https://doi.org/10.1038/s12276-018-0038-9 - DOI - PubMed`
│   inner_content: `Jeon SM, Shin EA (2018) Exploring __vitamin__ D metabolism and function in cancer. Exp Mol Med 50:1–14. https://doi.org/10.1038/s12276-018-0038-9 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Jeon SM, Shin EA (2018) Exploring `
│   │   inner_content: `Jeon SM, Shin EA (2018) Exploring `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D metabolism and function in cancer. Exp Mol Med 50:1–14. https://doi.org/10.1038/s12276-018-0038-9 - DOI - PubMed`
│   │   inner_content: ` D metabolism and function in cancer. Exp Mol Med 50:1–14. https://doi.org/10.1038/s12276-018-0038-9 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Marigoudar JB, Sarkar D, Yuguda YM, Abutayeh RF, Kaur A, Pati A, Mitra D et al (2022) Role of __vitamin__ D in targeting cancer and cancer stem cell populations and its therapeutic implications. Med Oncol 40:2. https://doi.org/10.1007/s12032-022-01855-0 - DOI - PubMed`
│   inner_content: `Marigoudar JB, Sarkar D, Yuguda YM, Abutayeh RF, Kaur A, Pati A, Mitra D et al (2022) Role of __vitamin__ D in targeting cancer and cancer stem cell populations and its therapeutic implications. Med Oncol 40:2. https://doi.org/10.1007/s12032-022-01855-0 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Marigoudar JB, Sarkar D, Yuguda YM, Abutayeh RF, Kaur A, Pati A, Mitra D et al (2022) Role of `
│   │   inner_content: `Marigoudar JB, Sarkar D, Yuguda YM, Abutayeh RF, Kaur A, Pati A, Mitra D et al (2022) Role of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D in targeting cancer and cancer stem cell populations and its therapeutic implications. Med Oncol 40:2. https://doi.org/10.1007/s12032-022-01855-0 - DOI - PubMed`
│   │   inner_content: ` D in targeting cancer and cancer stem cell populations and its therapeutic implications. Med Oncol 40:2. https://doi.org/10.1007/s12032-022-01855-0 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Chiang KC, Chen TC (2009) __vitamin__ D for the prevention and treatment of__ pancreatic cancer__. World J Gastroenterol 15:3349–3354. https://doi.org/10.3748/wjg.15.3349 - DOI - PubMed - PMC`
│   inner_content: `Chiang KC, Chen TC (2009) __vitamin__ D for the prevention and treatment of__ pancreatic cancer__. World J Gastroenterol 15:3349–3354. https://doi.org/10.3748/wjg.15.3349 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chiang KC, Chen TC (2009) `
│   │   inner_content: `Chiang KC, Chen TC (2009) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D for the prevention and treatment of`
│   │   inner_content: ` D for the prevention and treatment of`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `. World J Gastroenterol 15:3349–3354. https://doi.org/10.3748/wjg.15.3349 - DOI - PubMed - PMC`
│   │   inner_content: `. World J Gastroenterol 15:3349–3354. https://doi.org/10.3748/wjg.15.3349 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Mondul AM, Weinstein SJ, Layne TM, Albanes D (2017) __vitamin__ D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev 39:28–48. https://doi.org/10.1093/epirev/mxx005 - DOI - PubMed - PMC`
│   inner_content: `Mondul AM, Weinstein SJ, Layne TM, Albanes D (2017) __vitamin__ D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev 39:28–48. https://doi.org/10.1093/epirev/mxx005 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Mondul AM, Weinstein SJ, Layne TM, Albanes D (2017) `
│   │   inner_content: `Mondul AM, Weinstein SJ, Layne TM, Albanes D (2017) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev 39:28–48. https://doi.org/10.1093/epirev/mxx005 - DOI - PubMed - PMC`
│   │   inner_content: ` D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev 39:28–48. https://doi.org/10.1093/epirev/mxx005 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of__ pancreatic cancer__. J Natl Cancer Inst 105:1027–1035. https://doi.org/10.1093/jnci/djt123 - DOI - PubMed - PMC`
│   inner_content: `Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of__ pancreatic cancer__. J Natl Cancer Inst 105:1027–1035. https://doi.org/10.1093/jnci/djt123 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of`
│   │   inner_content: `Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `. J Natl Cancer Inst 105:1027–1035. https://doi.org/10.1093/jnci/djt123 - DOI - PubMed - PMC`
│   │   inner_content: `. J Natl Cancer Inst 105:1027–1035. https://doi.org/10.1093/jnci/djt123 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A (2010) 25-Hydroxy__vitamin__ D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18:1906–1910. https://doi.org/10.1038/oby.2010.11 - DOI - PubMed`
│   inner_content: `Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A (2010) 25-Hydroxy__vitamin__ D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18:1906–1910. https://doi.org/10.1038/oby.2010.11 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A (2010) 25-Hydroxy`
│   │   inner_content: `Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A (2010) 25-Hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18:1906–1910. https://doi.org/10.1038/oby.2010.11 - DOI - PubMed`
│   │   inner_content: ` D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18:1906–1910. https://doi.org/10.1038/oby.2010.11 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Vaidya A, Williams JS, Forman JP (2012) The independent association between 25-hydroxy__vitamin__ D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) 20:186–191. https://doi.org/10.1038/oby.2011.210 - DOI - PubMed`
│   inner_content: `Vaidya A, Williams JS, Forman JP (2012) The independent association between 25-hydroxy__vitamin__ D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) 20:186–191. https://doi.org/10.1038/oby.2011.210 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vaidya A, Williams JS, Forman JP (2012) The independent association between 25-hydroxy`
│   │   inner_content: `Vaidya A, Williams JS, Forman JP (2012) The independent association between 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) 20:186–191. https://doi.org/10.1038/oby.2011.210 - DOI - PubMed`
│   │   inner_content: ` D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) 20:186–191. https://doi.org/10.1038/oby.2011.210 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Earthman CP, Beckman LM, Masodkar K, Sibley SD (2012) The link between obesity and low circulating 25-hydroxy__vitamin__ D concentrations: considerations and implications. Int J Obes (Lond) 36:387–396. https://doi.org/10.1038/ijo.2011.119 - DOI - PubMed`
│   inner_content: `Earthman CP, Beckman LM, Masodkar K, Sibley SD (2012) The link between obesity and low circulating 25-hydroxy__vitamin__ D concentrations: considerations and implications. Int J Obes (Lond) 36:387–396. https://doi.org/10.1038/ijo.2011.119 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Earthman CP, Beckman LM, Masodkar K, Sibley SD (2012) The link between obesity and low circulating 25-hydroxy`
│   │   inner_content: `Earthman CP, Beckman LM, Masodkar K, Sibley SD (2012) The link between obesity and low circulating 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D concentrations: considerations and implications. Int J Obes (Lond) 36:387–396. https://doi.org/10.1038/ijo.2011.119 - DOI - PubMed`
│   │   inner_content: ` D concentrations: considerations and implications. Int J Obes (Lond) 36:387–396. https://doi.org/10.1038/ijo.2011.119 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#McPhail S, Johnson S, Greenberg D, Peake M, Rous B (2015) Stage at diagnosis and early mortality from cancer in England. Br J Cancer 112(Suppl 1):S108–S115. https://doi.org/10.1038/bjc.2015.49 - DOI - PubMed - PMC`
│   inner_content: `McPhail S, Johnson S, Greenberg D, Peake M, Rous B (2015) Stage at diagnosis and early mortality from cancer in England. Br J Cancer 112(Suppl 1):S108–S115. https://doi.org/10.1038/bjc.2015.49 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `McPhail S, Johnson S, Greenberg D, Peake M, Rous B (2015) Stage at diagnosis and early mortality from cancer in England. Br J Cancer 112(Suppl 1):S108–S115. https://doi.org/10.1038/bjc.2015.49 - DOI - PubMed - PMC`
│   │   inner_content: `McPhail S, Johnson S, Greenberg D, Peake M, Rous B (2015) Stage at diagnosis and early mortality from cancer in England. Br J Cancer 112(Suppl 1):S108–S115. https://doi.org/10.1038/bjc.2015.49 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Zwaigenbaum L, Stone W (2008) Early detection. Autism 12:427–432. https://doi.org/10.1177/1362361308097836 - DOI - PubMed`
│   inner_content: `Zwaigenbaum L, Stone W (2008) Early detection. Autism 12:427–432. https://doi.org/10.1177/1362361308097836 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zwaigenbaum L, Stone W (2008) Early detection. Autism 12:427–432. https://doi.org/10.1177/1362361308097836 - DOI - PubMed`
│   │   inner_content: `Zwaigenbaum L, Stone W (2008) Early detection. Autism 12:427–432. https://doi.org/10.1177/1362361308097836 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Fernández-Lázaro D, Seco-Calvo J (2023) Nutrition, nutritional status and functionality. Nutrients. https://doi.org/10.3390/nu15081944 - DOI - PubMed - PMC`
│   inner_content: `Fernández-Lázaro D, Seco-Calvo J (2023) Nutrition, nutritional status and functionality. Nutrients. https://doi.org/10.3390/nu15081944 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Fernández-Lázaro D, Seco-Calvo J (2023) Nutrition, nutritional status and functionality. Nutrients. https://doi.org/10.3390/nu15081944 - DOI - PubMed - PMC`
│   │   inner_content: `Fernández-Lázaro D, Seco-Calvo J (2023) Nutrition, nutritional status and functionality. Nutrients. https://doi.org/10.3390/nu15081944 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Zhang X, Chen Y, Jin S, Bi X, Chen D, Zhang D, Liu L et al (2020) Association of serum 25-Hydroxy__vitamin__ D with __vitamin__ D intervention and outdoor activity among children in North China: an observational study. BMC Pediatr 20:542. https://doi.org/10.1186/s12887-020-02435-9 - DOI - PubMed - PMC`
│   inner_content: `Zhang X, Chen Y, Jin S, Bi X, Chen D, Zhang D, Liu L et al (2020) Association of serum 25-Hydroxy__vitamin__ D with __vitamin__ D intervention and outdoor activity among children in North China: an observational study. BMC Pediatr 20:542. https://doi.org/10.1186/s12887-020-02435-9 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zhang X, Chen Y, Jin S, Bi X, Chen D, Zhang D, Liu L et al (2020) Association of serum 25-Hydroxy`
│   │   inner_content: `Zhang X, Chen Y, Jin S, Bi X, Chen D, Zhang D, Liu L et al (2020) Association of serum 25-Hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D with `
│   │   inner_content: ` D with `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D intervention and outdoor activity among children in North China: an observational study. BMC Pediatr 20:542. https://doi.org/10.1186/s12887-020-02435-9 - DOI - PubMed - PMC`
│   │   inner_content: ` D intervention and outdoor activity among children in North China: an observational study. BMC Pediatr 20:542. https://doi.org/10.1186/s12887-020-02435-9 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Holick MF (2017) The __vitamin__ D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18:153–165. https://doi.org/10.1007/s11154-017-9424-1 - DOI - PubMed`
│   inner_content: `Holick MF (2017) The __vitamin__ D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18:153–165. https://doi.org/10.1007/s11154-017-9424-1 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Holick MF (2017) The `
│   │   inner_content: `Holick MF (2017) The `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18:153–165. https://doi.org/10.1007/s11154-017-9424-1 - DOI - PubMed`
│   │   inner_content: ` D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18:153–165. https://doi.org/10.1007/s11154-017-9424-1 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, Stolzenberg-Solomon RZ et al (2018) Circulating 25-hydroxy__vitamin__ D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol 33:1087–1099. https://doi.org/10.1007/s10654-018-0428-2 - DOI - PubMed - PMC`
│   inner_content: `Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, Stolzenberg-Solomon RZ et al (2018) Circulating 25-hydroxy__vitamin__ D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol 33:1087–1099. https://doi.org/10.1007/s10654-018-0428-2 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, Stolzenberg-Solomon RZ et al (2018) Circulating 25-hydroxy`
│   │   inner_content: `Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, Stolzenberg-Solomon RZ et al (2018) Circulating 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol 33:1087–1099. https://doi.org/10.1007/s10654-018-0428-2 - DOI - PubMed - PMC`
│   │   inner_content: ` D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol 33:1087–1099. https://doi.org/10.1007/s10654-018-0428-2 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Rasmussen LS, Yilmaz MK, Falkmer UG, Poulsen L, Bøgsted M, Christensen HS, Bojesen SE et al (2021) Pre-treatment serum __vitamin__ D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with__ pancreatic cancer__. Eur J Cancer 144:72–80. https://doi.org/10.1016/j.ejca.2020.10.038 - DOI - PubMed`
│   inner_content: `Rasmussen LS, Yilmaz MK, Falkmer UG, Poulsen L, Bøgsted M, Christensen HS, Bojesen SE et al (2021) Pre-treatment serum __vitamin__ D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with__ pancreatic cancer__. Eur J Cancer 144:72–80. https://doi.org/10.1016/j.ejca.2020.10.038 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Rasmussen LS, Yilmaz MK, Falkmer UG, Poulsen L, Bøgsted M, Christensen HS, Bojesen SE et al (2021) Pre-treatment serum `
│   │   inner_content: `Rasmussen LS, Yilmaz MK, Falkmer UG, Poulsen L, Bøgsted M, Christensen HS, Bojesen SE et al (2021) Pre-treatment serum `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with`
│   │   inner_content: ` D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `. Eur J Cancer 144:72–80. https://doi.org/10.1016/j.ejca.2020.10.038 - DOI - PubMed`
│   │   inner_content: `. Eur J Cancer 144:72–80. https://doi.org/10.1016/j.ejca.2020.10.038 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, Schulz C et al (2015) Assessing novel prognostic serum biomarkers in advanced__ pancreatic cancer__: the role of CYFRA 21–1, serum amyloid A, haptoglobin, and 25-OH __vitamin__ D3. Tumour Biol 36:2631–2640. https://doi.org/10.1007/s13277-014-2885-x - DOI - PubMed`
│   inner_content: `Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, Schulz C et al (2015) Assessing novel prognostic serum biomarkers in advanced__ pancreatic cancer__: the role of CYFRA 21–1, serum amyloid A, haptoglobin, and 25-OH __vitamin__ D3. Tumour Biol 36:2631–2640. https://doi.org/10.1007/s13277-014-2885-x - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, Schulz C et al (2015) Assessing novel prognostic serum biomarkers in advanced`
│   │   inner_content: `Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, Schulz C et al (2015) Assessing novel prognostic serum biomarkers in advanced`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `: the role of CYFRA 21–1, serum amyloid A, haptoglobin, and 25-OH `
│   │   inner_content: `: the role of CYFRA 21–1, serum amyloid A, haptoglobin, and 25-OH `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3. Tumour Biol 36:2631–2640. https://doi.org/10.1007/s13277-014-2885-x - DOI - PubMed`
│   │   inner_content: ` D3. Tumour Biol 36:2631–2640. https://doi.org/10.1007/s13277-014-2885-x - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB (2016) Retrospective analysis of the influence of 25-hydroxy__vitamin__ D on disease progression and survival in__ pancreatic cancer__. Nutr J 15:17. https://doi.org/10.1186/s12937-016-0135-3 - DOI - PubMed - PMC`
│   inner_content: `McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB (2016) Retrospective analysis of the influence of 25-hydroxy__vitamin__ D on disease progression and survival in__ pancreatic cancer__. Nutr J 15:17. https://doi.org/10.1186/s12937-016-0135-3 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB (2016) Retrospective analysis of the influence of 25-hydroxy`
│   │   inner_content: `McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB (2016) Retrospective analysis of the influence of 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D on disease progression and survival in`
│   │   inner_content: ` D on disease progression and survival in`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `. Nutr J 15:17. https://doi.org/10.1186/s12937-016-0135-3 - DOI - PubMed - PMC`
│   │   inner_content: `. Nutr J 15:17. https://doi.org/10.1186/s12937-016-0135-3 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#LeFevre ML (2015) Screening for __vitamin__ D deficiency in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 162:133–140. https://doi.org/10.7326/m14-2450 - DOI - PubMed`
│   inner_content: `LeFevre ML (2015) Screening for __vitamin__ D deficiency in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 162:133–140. https://doi.org/10.7326/m14-2450 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `LeFevre ML (2015) Screening for `
│   │   inner_content: `LeFevre ML (2015) Screening for `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 162:133–140. https://doi.org/10.7326/m14-2450 - DOI - PubMed`
│   │   inner_content: ` D deficiency in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 162:133–140. https://doi.org/10.7326/m14-2450 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Kantor ED, Rehm CD, Du M, White E, Giovannucci EL (2016) Trends in dietary supplement use among US adults from 1999–2012. JAMA 316:1464–1474. https://doi.org/10.1001/jama.2016.14403 - DOI - PubMed - PMC`
│   inner_content: `Kantor ED, Rehm CD, Du M, White E, Giovannucci EL (2016) Trends in dietary supplement use among US adults from 1999–2012. JAMA 316:1464–1474. https://doi.org/10.1001/jama.2016.14403 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kantor ED, Rehm CD, Du M, White E, Giovannucci EL (2016) Trends in dietary supplement use among US adults from 1999–2012. JAMA 316:1464–1474. https://doi.org/10.1001/jama.2016.14403 - DOI - PubMed - PMC`
│   │   inner_content: `Kantor ED, Rehm CD, Du M, White E, Giovannucci EL (2016) Trends in dietary supplement use among US adults from 1999–2012. JAMA 316:1464–1474. https://doi.org/10.1001/jama.2016.14403 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Adams JS, Hewison M (2012) Extrarenal expression of the 25-hydroxy__vitamin__ D-1-hydroxylase. Arch Biochem Biophys 523:95–102. https://doi.org/10.1016/j.abb.2012.02.016 - DOI - PubMed - PMC`
│   inner_content: `Adams JS, Hewison M (2012) Extrarenal expression of the 25-hydroxy__vitamin__ D-1-hydroxylase. Arch Biochem Biophys 523:95–102. https://doi.org/10.1016/j.abb.2012.02.016 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Adams JS, Hewison M (2012) Extrarenal expression of the 25-hydroxy`
│   │   inner_content: `Adams JS, Hewison M (2012) Extrarenal expression of the 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D-1-hydroxylase. Arch Biochem Biophys 523:95–102. https://doi.org/10.1016/j.abb.2012.02.016 - DOI - PubMed - PMC`
│   │   inner_content: ` D-1-hydroxylase. Arch Biochem Biophys 523:95–102. https://doi.org/10.1016/j.abb.2012.02.016 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C (1996) Growth-inhibitory effects of __vitamin__ D analogues and retinoids on human__ pancreatic cancer__ cells. Br J Cancer 73:1341–1346. https://doi.org/10.1038/bjc.1996.256 - DOI - PubMed - PMC`
│   inner_content: `Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C (1996) Growth-inhibitory effects of __vitamin__ D analogues and retinoids on human__ pancreatic cancer__ cells. Br J Cancer 73:1341–1346. https://doi.org/10.1038/bjc.1996.256 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C (1996) Growth-inhibitory effects of `
│   │   inner_content: `Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C (1996) Growth-inhibitory effects of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D analogues and retinoids on human`
│   │   inner_content: ` D analogues and retinoids on human`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` cells. Br J Cancer 73:1341–1346. https://doi.org/10.1038/bjc.1996.256 - DOI - PubMed - PMC`
│   │   inner_content: ` cells. Br J Cancer 73:1341–1346. https://doi.org/10.1038/bjc.1996.256 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Schwartz GG, Eads D, Naczki C, Northrup S, Chen T, Koumenis C (2008) 19-nor-1 alpha,25-dihydroxy__vitamin__ D2 (paricalcitol) inhibits the proliferation of human__ pancreatic cancer__ cells in vitro and in vivo. Cancer Biol Ther 7:430–436. https://doi.org/10.4161/cbt.7.3.5418 - DOI - PubMed`
│   inner_content: `Schwartz GG, Eads D, Naczki C, Northrup S, Chen T, Koumenis C (2008) 19-nor-1 alpha,25-dihydroxy__vitamin__ D2 (paricalcitol) inhibits the proliferation of human__ pancreatic cancer__ cells in vitro and in vivo. Cancer Biol Ther 7:430–436. https://doi.org/10.4161/cbt.7.3.5418 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Schwartz GG, Eads D, Naczki C, Northrup S, Chen T, Koumenis C (2008) 19-nor-1 alpha,25-dihydroxy`
│   │   inner_content: `Schwartz GG, Eads D, Naczki C, Northrup S, Chen T, Koumenis C (2008) 19-nor-1 alpha,25-dihydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D2 (paricalcitol) inhibits the proliferation of human`
│   │   inner_content: ` D2 (paricalcitol) inhibits the proliferation of human`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` cells in vitro and in vivo. Cancer Biol Ther 7:430–436. https://doi.org/10.4161/cbt.7.3.5418 - DOI - PubMed`
│   │   inner_content: ` cells in vitro and in vivo. Cancer Biol Ther 7:430–436. https://doi.org/10.4161/cbt.7.3.5418 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Albrechtsson E, Jonsson T, Möller S, Höglund M, Ohlsson B, Axelson J (2003) __vitamin__ D receptor is expressed in__ pancreatic cancer__ cells and a __vitamin__ D3 analogue decreases cell number. Pancreatology 3:41–46. https://doi.org/10.1159/000069149 - DOI - PubMed`
│   inner_content: `Albrechtsson E, Jonsson T, Möller S, Höglund M, Ohlsson B, Axelson J (2003) __vitamin__ D receptor is expressed in__ pancreatic cancer__ cells and a __vitamin__ D3 analogue decreases cell number. Pancreatology 3:41–46. https://doi.org/10.1159/000069149 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Albrechtsson E, Jonsson T, Möller S, Höglund M, Ohlsson B, Axelson J (2003) `
│   │   inner_content: `Albrechtsson E, Jonsson T, Möller S, Höglund M, Ohlsson B, Axelson J (2003) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D receptor is expressed in`
│   │   inner_content: ` D receptor is expressed in`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` cells and a `
│   │   inner_content: ` cells and a `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 analogue decreases cell number. Pancreatology 3:41–46. https://doi.org/10.1159/000069149 - DOI - PubMed`
│   │   inner_content: ` D3 analogue decreases cell number. Pancreatology 3:41–46. https://doi.org/10.1159/000069149 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Armas LA, Hollis BW, Heaney RP (2004) __vitamin__ D2 is much less effective than __vitamin__ D3 in humans. J Clin Endocrinol Metab 89:5387–5391. https://doi.org/10.1210/jc.2004-0360 - DOI - PubMed`
│   inner_content: `Armas LA, Hollis BW, Heaney RP (2004) __vitamin__ D2 is much less effective than __vitamin__ D3 in humans. J Clin Endocrinol Metab 89:5387–5391. https://doi.org/10.1210/jc.2004-0360 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Armas LA, Hollis BW, Heaney RP (2004) `
│   │   inner_content: `Armas LA, Hollis BW, Heaney RP (2004) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D2 is much less effective than `
│   │   inner_content: ` D2 is much less effective than `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 in humans. J Clin Endocrinol Metab 89:5387–5391. https://doi.org/10.1210/jc.2004-0360 - DOI - PubMed`
│   │   inner_content: ` D3 in humans. J Clin Endocrinol Metab 89:5387–5391. https://doi.org/10.1210/jc.2004-0360 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Skinner HG (2008) __vitamin__ D for the treatment and prevention of__ pancreatic cancer__. Cancer Biol Ther 7:437–439. https://doi.org/10.4161/cbt.7.3.5585 - DOI - PubMed`
│   inner_content: `Skinner HG (2008) __vitamin__ D for the treatment and prevention of__ pancreatic cancer__. Cancer Biol Ther 7:437–439. https://doi.org/10.4161/cbt.7.3.5585 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Skinner HG (2008) `
│   │   inner_content: `Skinner HG (2008) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D for the treatment and prevention of`
│   │   inner_content: ` D for the treatment and prevention of`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `. Cancer Biol Ther 7:437–439. https://doi.org/10.4161/cbt.7.3.5585 - DOI - PubMed`
│   │   inner_content: `. Cancer Biol Ther 7:437–439. https://doi.org/10.4161/cbt.7.3.5585 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA et al (2014) __vitamin__ D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances__ pancreatic cancer__ therapy. Cell 159:80–93. https://doi.org/10.1016/j.cell.2014.08.007 - DOI - PubMed - PMC`
│   inner_content: `Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA et al (2014) __vitamin__ D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances__ pancreatic cancer__ therapy. Cell 159:80–93. https://doi.org/10.1016/j.cell.2014.08.007 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA et al (2014) `
│   │   inner_content: `Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA et al (2014) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances`
│   │   inner_content: ` D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` therapy. Cell 159:80–93. https://doi.org/10.1016/j.cell.2014.08.007 - DOI - PubMed - PMC`
│   │   inner_content: ` therapy. Cell 159:80–93. https://doi.org/10.1016/j.cell.2014.08.007 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Hennig R, Ding XZ, Adrian TE (2004) On the role of the islets of Langerhans in__ pancreatic cancer__. Histol Histopathol 19:999–1011. https://doi.org/10.14670/hh-19.999`
│   inner_content: `Hennig R, Ding XZ, Adrian TE (2004) On the role of the islets of Langerhans in__ pancreatic cancer__. Histol Histopathol 19:999–1011. https://doi.org/10.14670/hh-19.999`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Hennig R, Ding XZ, Adrian TE (2004) On the role of the islets of Langerhans in`
│   │   inner_content: `Hennig R, Ding XZ, Adrian TE (2004) On the role of the islets of Langerhans in`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: `. Histol Histopathol 19:999–1011. https://doi.org/10.14670/hh-19.999`
│   │   inner_content: `. Histol Histopathol 19:999–1011. https://doi.org/10.14670/hh-19.999`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bear AS, Vonderheide RH, O’Hara MH (2020) Challenges and opportunities for__ pancreatic cancer__ immunotherapy. Cancer Cell 38:788–802. https://doi.org/10.1016/j.ccell.2020.08.004 - DOI - PubMed - PMC`
│   inner_content: `Bear AS, Vonderheide RH, O’Hara MH (2020) Challenges and opportunities for__ pancreatic cancer__ immunotherapy. Cancer Cell 38:788–802. https://doi.org/10.1016/j.ccell.2020.08.004 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bear AS, Vonderheide RH, O’Hara MH (2020) Challenges and opportunities for`
│   │   inner_content: `Bear AS, Vonderheide RH, O’Hara MH (2020) Challenges and opportunities for`
│   ├── BoldNode
│   │   full_match: `__ pancreatic cancer__`
│   │   inner_content: ` pancreatic cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ` pancreatic cancer`
│   │   │   inner_content: ` pancreatic cancer`
│   ├── TextNode
│   │   full_match: ` immunotherapy. Cancer Cell 38:788–802. https://doi.org/10.1016/j.ccell.2020.08.004 - DOI - PubMed - PMC`
│   │   inner_content: ` immunotherapy. Cancer Cell 38:788–802. https://doi.org/10.1016/j.ccell.2020.08.004 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Maestro B, Molero S, Bajo S, Dávila N, Calle C (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxy__vitamin__ D(3). Cell Biochem Funct 20:227–232. https://doi.org/10.1002/cbf.951 - DOI - PubMed`
│   inner_content: `Maestro B, Molero S, Bajo S, Dávila N, Calle C (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxy__vitamin__ D(3). Cell Biochem Funct 20:227–232. https://doi.org/10.1002/cbf.951 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Maestro B, Molero S, Bajo S, Dávila N, Calle C (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxy`
│   │   inner_content: `Maestro B, Molero S, Bajo S, Dávila N, Calle C (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D(3). Cell Biochem Funct 20:227–232. https://doi.org/10.1002/cbf.951 - DOI - PubMed`
│   │   inner_content: ` D(3). Cell Biochem Funct 20:227–232. https://doi.org/10.1002/cbf.951 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxy__vitamin__ D3 receptors in human leukocytes. Science 221:1181–1183. https://doi.org/10.1126/science.6310748 - DOI - PubMed`
│   inner_content: `Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxy__vitamin__ D3 receptors in human leukocytes. Science 221:1181–1183. https://doi.org/10.1126/science.6310748 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxy`
│   │   inner_content: `Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 receptors in human leukocytes. Science 221:1181–1183. https://doi.org/10.1126/science.6310748 - DOI - PubMed`
│   │   inner_content: ` D3 receptors in human leukocytes. Science 221:1181–1183. https://doi.org/10.1126/science.6310748 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxy__vitamin__ D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657–661. https://doi.org/10.1172/jci111465 - DOI - PubMed - PMC`
│   inner_content: `Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxy__vitamin__ D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657–661. https://doi.org/10.1172/jci111465 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxy`
│   │   inner_content: `Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657–661. https://doi.org/10.1172/jci111465 - DOI - PubMed - PMC`
│   │   inner_content: ` D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657–661. https://doi.org/10.1172/jci111465 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxy__vitamin__ D3 on human B cell differentiation. J Immunol 179:1634–1647. https://doi.org/10.4049/jimmunol.179.3.1634 - DOI - PubMed`
│   inner_content: `Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxy__vitamin__ D3 on human B cell differentiation. J Immunol 179:1634–1647. https://doi.org/10.4049/jimmunol.179.3.1634 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxy`
│   │   inner_content: `Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 on human B cell differentiation. J Immunol 179:1634–1647. https://doi.org/10.4049/jimmunol.179.3.1634 - DOI - PubMed`
│   │   inner_content: ` D3 on human B cell differentiation. J Immunol 179:1634–1647. https://doi.org/10.4049/jimmunol.179.3.1634 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of __vitamin__ D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932. https://doi.org/10.1002/jcb.10580 - DOI - PubMed`
│   inner_content: `Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of __vitamin__ D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932. https://doi.org/10.1002/jcb.10580 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of `
│   │   inner_content: `Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932. https://doi.org/10.1002/jcb.10580 - DOI - PubMed`
│   │   inner_content: ` D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932. https://doi.org/10.1002/jcb.10580 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) __vitamin__ D: modulator of the immune system. Curr Opin Pharmacol 10:482–496. https://doi.org/10.1016/j.coph.2010.04.001 - DOI - PubMed`
│   inner_content: `Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) __vitamin__ D: modulator of the immune system. Curr Opin Pharmacol 10:482–496. https://doi.org/10.1016/j.coph.2010.04.001 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) `
│   │   inner_content: `Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D: modulator of the immune system. Curr Opin Pharmacol 10:482–496. https://doi.org/10.1016/j.coph.2010.04.001 - DOI - PubMed`
│   │   inner_content: ` D: modulator of the immune system. Curr Opin Pharmacol 10:482–496. https://doi.org/10.1016/j.coph.2010.04.001 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Mora JR, Iwata M, von Andrian UH (2008) __vitamin__ effects on the immune system: __vitamin__s A and D take centre stage. Nat Rev Immunol 8:685–698. https://doi.org/10.1038/nri2378 - DOI - PubMed - PMC`
│   inner_content: `Mora JR, Iwata M, von Andrian UH (2008) __vitamin__ effects on the immune system: __vitamin__s A and D take centre stage. Nat Rev Immunol 8:685–698. https://doi.org/10.1038/nri2378 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Mora JR, Iwata M, von Andrian UH (2008) `
│   │   inner_content: `Mora JR, Iwata M, von Andrian UH (2008) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` effects on the immune system: `
│   │   inner_content: ` effects on the immune system: `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: `s A and D take centre stage. Nat Rev Immunol 8:685–698. https://doi.org/10.1038/nri2378 - DOI - PubMed - PMC`
│   │   inner_content: `s A and D take centre stage. Nat Rev Immunol 8:685–698. https://doi.org/10.1038/nri2378 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC (1985) 1,25-Dihydroxy__vitamin__ D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134:3032–3035 - DOI - PubMed`
│   inner_content: `Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC (1985) 1,25-Dihydroxy__vitamin__ D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134:3032–3035 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC (1985) 1,25-Dihydroxy`
│   │   inner_content: `Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC (1985) 1,25-Dihydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134:3032–3035 - DOI - PubMed`
│   │   inner_content: ` D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134:3032–3035 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Schlingmann KP (2021) __vitamin__ D-dependent Hypercalcemia. Endocrinol Metab Clin North Am 50:729–742. https://doi.org/10.1016/j.ecl.2021.08.005 - DOI - PubMed`
│   inner_content: `Schlingmann KP (2021) __vitamin__ D-dependent Hypercalcemia. Endocrinol Metab Clin North Am 50:729–742. https://doi.org/10.1016/j.ecl.2021.08.005 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Schlingmann KP (2021) `
│   │   inner_content: `Schlingmann KP (2021) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D-dependent Hypercalcemia. Endocrinol Metab Clin North Am 50:729–742. https://doi.org/10.1016/j.ecl.2021.08.005 - DOI - PubMed`
│   │   inner_content: ` D-dependent Hypercalcemia. Endocrinol Metab Clin North Am 50:729–742. https://doi.org/10.1016/j.ecl.2021.08.005 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Tebben PJ, Singh RJ, Kumar R (2016) __vitamin__ D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37:521–547. https://doi.org/10.1210/er.2016-1070 - DOI - PubMed - PMC`
│   inner_content: `Tebben PJ, Singh RJ, Kumar R (2016) __vitamin__ D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37:521–547. https://doi.org/10.1210/er.2016-1070 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Tebben PJ, Singh RJ, Kumar R (2016) `
│   │   inner_content: `Tebben PJ, Singh RJ, Kumar R (2016) `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37:521–547. https://doi.org/10.1210/er.2016-1070 - DOI - PubMed - PMC`
│   │   inner_content: ` D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37:521–547. https://doi.org/10.1210/er.2016-1070 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S et al (2009) Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice–the ECHO observational study. Nephrol Dial Transpl 24:2852–2859. https://doi.org/10.1093/ndt/gfp144 - DOI`
│   inner_content: `Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S et al (2009) Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice–the ECHO observational study. Nephrol Dial Transpl 24:2852–2859. https://doi.org/10.1093/ndt/gfp144 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S et al (2009) Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice–the ECHO observational study. Nephrol Dial Transpl 24:2852–2859. https://doi.org/10.1093/ndt/gfp144 - DOI`
│   │   inner_content: `Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S et al (2009) Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice–the ECHO observational study. Nephrol Dial Transpl 24:2852–2859. https://doi.org/10.1093/ndt/gfp144 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ et al (2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70:351–357. https://doi.org/10.1038/sj.ki.5001542 - DOI - PubMed`
│   inner_content: `Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ et al (2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70:351–357. https://doi.org/10.1038/sj.ki.5001542 - DOI - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ et al (2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70:351–357. https://doi.org/10.1038/sj.ki.5001542 - DOI - PubMed`
│   │   inner_content: `Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ et al (2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70:351–357. https://doi.org/10.1038/sj.ki.5001542 - DOI - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Cancer - Pancreatic)) category contains`
│   inner_content: `VitaminDWiki – ((Cancer - Pancreatic)) category contains`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Cancer - Pancreatic))`
│   │   inner_content: `Cancer - Pancreatic`
│   │   page: `Cancer - Pancreatic`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Cancer - Pancreatic`
│   │   │   inner_content: `Cancer - Pancreatic`
│   ├── TextNode
│   │   full_match: ` category contains`
│   │   inner_content: ` category contains`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Cancer - Pancreatic&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Cancer - Pancreatic&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Cancer - Pancreatic
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!~~#F06:81+~~  VitaminDWiki Cancer meta-analyses`
│   inner_content: `~~#F06:81+~~  VitaminDWiki Cancer meta-analyses`
│   level: `4`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#F06:81+~~`
│   │   inner_content: `81+`
│   │   attrs_dict:
│   │   │   raw_content: #F06
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `81+`
│   │   │   inner_content: `81+`
│   ├── TextNode
│   │   full_match: `  VitaminDWiki Cancer meta-analyses`
│   │   inner_content: `  VitaminDWiki Cancer meta-analyses`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── EmphasisNode
│   full_match: `&#39;&#39;This list is automatically updated&#39;&#39;`
│   inner_content: `This list is automatically updated`
│   children:
│   ├── TextNode
│   │   full_match: `This list is automatically updated`
│   │   inner_content: `This list is automatically updated`├── TextNode
│   full_match: `\n{LIST()}\n{list max=&quot;150&quot;}\n`
│   inner_content: `\n{LIST()}\n{list max=&quot;150&quot;}\n`├── FilterNode
│   full_match: `{filter categories=&quot;82&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: categories=&quot;82&quot;
│   │   categories: 82├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── FilterNode
│   full_match: `{filter field=&quot;title&quot; content=&quot;cancer&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: field=&quot;title&quot; content=&quot;cancer&quot;
│   │   field: title
│   │   content: cancer├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── FilterNode
│   full_match: `{filter type=&quot;wiki page&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: type=&quot;wiki page&quot;
│   │   type: wiki page├── TextNode
│   full_match: `\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}n\n    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}\n\n`
│   inner_content: `\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}n\n    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}\n\n`├── TikiCommentNode
│   full_match: `~tc~ (alias(Pancreatic Cancer survival 2.3 X more likely if good level of Vitamin D – meta-analysis  Sept 2023)) ~/tc~`
│   inner_content: ` (alias(Pancreatic Cancer survival 2.3 X more likely if good level of Vitamin D – meta-analysis  Sept 2023)) `
│   children:
│   ├── TextNode
│   │   full_match: ` (alias(Pancreatic Cancer survival 2.3 X more likely if good level of Vitamin D – meta-analysis  Sept 2023)) `
│   │   inner_content: ` (alias(Pancreatic Cancer survival 2.3 X more likely if good level of Vitamin D – meta-analysis  Sept 2023)) `

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!There are 2 meta-analyses on this page
---
!!!!25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis - 2023
Nutrition Research Vol 117, Sept 2023, Pages 73-82 [https://doi.org/10.1016/j.nutres.2023.07.001] PDF is behind a paywall
Jing Li a #, Haiyan Zhang a #, Hongda Zhu b, Zhu Dai a

Studies have shown that 25-hydroxyvitamin D (25(OH)D) is predictive of survival following a diagnosis of cancer. However, evidence of the relationship between 25(OH)D and the survival of patients with pancreatic cancer has been inconsistent. We hypothesized that circulating 25(OH)D concentrations may be positively correlated with better prognosis in advanced pancreatic cancer. PubMed, EMBASE, Cochrane Library, and Web of Science database entries through April 2023, along with the reference lists of related studies, were searched. Additionally, we extracted observational studies reporting the association between 25(OH)D concentrations and the outcome of interest (overall survival [OS]) in advanced pancreatic cancer patients aged 18 years or older. Ultimately, 7 articles involving 2369 patients were included in this systematic review and meta-analysis. The results indicated that 25(OH)D concentrations were positively correlated with __OS (hazard ratio = 2.37__; 95% confidence interval, 2.22–2.54; P &lt; .001). No association was found between 25(OH)D and progression-free survival. There was significant heterogeneity between studies in terms of OS (I2 = 85.5%, P &lt; .001). Our subgroup analysis revealed that this high heterogeneity may be attributed to the studies’ different regions, designs, sample sources, and detection methods of 25(OH)D. Additionally, Begg&#39;s and Egger&#39;s tests indicated the presence of publication bias. To our knowledge, this is the first meta-analysis to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer. Our results suggested that circulating 25(OH)D concentrations were positively correlated with OS, indicating that 25(OH)D may be a potential prognostic marker in advanced pancreatic cancer.

Graphical abstract
This systematic review and meta-analysis was performed to evaluate the association between circulating 25-hydroxyvitamin D (25(OH)D) concentration and survival outcomes among patients with advanced pancreatic cancer. The results showed that 25(OH)D concentrations were positively correlated with overall survival among patients with pancreatic cancer, indicating that 25(OH)D concentration may be a potential prognostic marker in advanced pancreatic cancer.

Introduction
Pancreatic cancer is considered a fatal disease and is 1 of the most aggressive and deadly types of malignant tumors [1]. It has been reported that the 5-year survival rate of patients with pancreatic cancer varies in different regions and countries in the world; however, these rates have consistently remained below 10% [2]. This is partly because pancreatic cancer tends to metastasize to lymph nodes or distant sites at an early stage because of its high capacity for invasion and migration [3]. To date, except for the onset stage, there are few known patient characteristics or circulating markers that can predict the survival time of patients with pancreatic cancer.

The classical role of vitamin D (VD) is to maintain calcium homeostasis and help regulate bone metabolism [4]. Initially, it was considered to have autocrine and paracrine effects until the discovery that multiple cells throughout the body can express both vitamin D receptors (VDRs) and the hydroxylase necessary to produce calcitriol [5]. VD is predominantly synthesized from 7-dehydrocholesterol in the skin on exposure to sunlight, whereas the remaining VD is obtained from dietary sources. VD itself has low activity at physiological concentrations and requires 2 successive hydroxylation reactions. It is first metabolized by 25-hydroxylase (CYP2R1 and CYP27A1) to 25-hydroxyvitamin D (25(OH)D) in the liver. Notably, 25(OH)D is the primary circulating form of VD and a clinical marker. Subsequently, 25(OH)D is further metabolized by 1α-hydroxylase, mainly in the proximal tubule of the kidney, to 1α,25-dihydroxyvitamin D [6], the most biologically active form of VD. It can bind to VDRs that influence target genes involved in intracellular signaling pathways, including cell growth, differentiation, adhesion, and apoptosis [7]. This altered cellular mechanism plays a key role in cancer development and suggests a potential relationship between VD and cancer.

Multiple experimental studies have indicated that VD participates in pancreatic carcinogenesis and demonstrated the therapeutic potential of VD analogs via the engagement of VDRs in tumor and supportive cells within the tumor stroma [8,9]. Notably, an inverse association between serum 25(OH)D concentration and risk for cancer has been commonly reported in epidemiological studies [10]. Additionally, there is widespread interest in evaluating the association between circulating 25(OH)D and patient prognosis. Some clinical studies have revealed longer overall survival (OS) in patients with pancreatic cancer and sufficient 25(OH)D concentrations [11]. However, the results of this type of study were inconsistent with those of other studies, showing no significant relationship between circulating 25(OH)D concentrations and survival outcomes [12].

Therefore, to assess the effect of 25(OH)D on survival outcomes in advanced pancreatic cancer patients, we performed a systematic review and meta-analysis to evaluate the association between circulating 25(OH)D concentrations and OS. We hypothesized that 25(OH)D concentrations may be positively correlated with OS in advanced pancreatic cancer.

!!!!!Section snippets
Literature search
We searched PubMed, EMBASE, Web of Science, and Cochrane library databases (on April 2023) for cohort studies assessing the association between circulating 25(OH)D concentrations and OS in patients with advanced pancreatic cancers. Medical Subject Headings including “Pancreatic Neoplasms” and “Vitamin D” were used to choose qualified studies, and these were further combined with keyword searches in titles and abstracts. Additionally, the references cited in all selected studies and published…

Study selection
A flowchart of the study retrieval process is shown in Fig. 1. A total of 2166 potential studies were identified from the initial search of the previously mentioned databases, of which 538 were duplicates. After removing duplicate records and screening the titles and abstracts, 846 records remained. The full-text documents of these records were assessed, resulting in the exclusion of __839 records__. The exclusion criteria were as follows: (1) review articles (n = 445); (2) animal experiments (n…

Discussion
This meta-analysis is the first to evaluate the association between 25(OH)D concentrations and OS among patients with pancreatic cancer and to assess the potential prognostic value of 25(OH)D. Our results supported the notion that a positive correlation existed between 25(OH)D and OS in patients with pancreatic cancer, which was consistent with our hypothesis.

Pancreatic cancer is a prevalent disease characterized by a low survival rate, primarily because it is often detected at advanced stages, …

Conclusion
In conclusion, our study indicated that 25(OH)D concentrations were positively correlated with OS, which may provide useful prognostic information for advanced pancreatic cancer patients. However, more studies are needed to validate this finding, and the mechanism behind the observation should be evaluated in further studies…
---
!!!!!Some titles of references
*Vitamin D and pancreatic cancer
*Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications
*Vitamin D for cancer prevention: global perspective
*Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number
*The vitamin D system is deregulated in pancreatic diseases
*Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis
*Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study
*The vitamin D dose response in obesity
*High prevalence of vitamin D deficiency in urban health checkup population
*Vitamin D, parathyroid hormone, and cardiovascular events among older adults
*Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in t 47d breast cancer cells
*Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression
*Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
*Current epidemiology of pancreatic cancer: challenges and opportunities
*Pancreatic cancer: a review of epidemiology, trend, and risk factors
*Pancreatic cancer: a review of current treatment and novel therapies
*Vitamin D binding protein and bone health
*Sex differences in vitamin D metabolism, serum levels and action
*Calcipotriol targets lrp6 to inhibit wnt signaling in pancreatic cancer
*Activation of vitamin D receptor signaling downregulates the expression of nuclear foxm1 protein and suppresses pancreatic cancer cell stemness
*Vitamin D for the prevention and treatment of pancreatic cancer
*Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival
---
!!!!40% less likely to die of Pancreatic Cancer if high vitamin D - meta-analyis Jan 2024
__The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies__
Eur J Nutr. 2024 Jan 3. doi: [10.1007/s00394-023-03302-w] PDF behind paywall
Yajing Shen 1 2, Junfen Xia 3, Chuncheng Yi 1 2, Tiandong Li 1 2, Peng Wang 1 2, Liping Dai 2 4, Jianxiang Shi 2 4, Keyan Wang 2 4, Changqing Sun 1 5, Hua Ye 6 7

Purpose: The relationship between circulating 25-hydroxyvitamin D [25(OH)D] and pancreatic cancer has been well studied but remains unclear. The purpose of this study was to elucidate the association between circulating 25(OH)D and pancreatic cancer by using a meta-analytic approach.

Methods: PubMed, Embase, and Wed of Science databases were searched through October 15, 2022. A random or fixed-effects model was used to estimate the pooled odds ratio (OR), risk ratio (RR), hazard ratio (HR) and their 95% confidence intervals (CIs).

Results: A total of 16 studies including 529,917 participants met the inclusion criteria, of which 10 reported incidence and 6 reported mortality. For the highest versus lowest categories of circulating 25(OH)D, the pooled OR of pancreatic cancer incidence in case-control studies was 0.98 (95% CI 0.69-1.27), and the pooled HRs of pancreatic cancer mortality in cohort and case-control studies were __0.64__ (95% CI 0.45-0.82) and 0.78 (95% CI 0.62-0.95), respectively. The leave-one-out sensitivity analyses found no outliers and Galbraith plots indicated no substantial heterogeneity.

Conclusion: Evidence from this meta-analysis suggested that high circulating 25(OH)D levels may be associated with decreased mortality but not incidence of pancreatic cancer. Our findings may provide some clues for the treatment of pancreatic cancer and remind us to be cautious about widespread vitamin D supplementation for the prevention of pancreatic cancer.
!!!!!95 References
#Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed
#Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48. https://doi.org/10.3322/caac.21763 - DOI - PubMed
#You L, Lv Z, Li C, Ye W, Zhou Y, Jin J, Han Q (2021) Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019. ESMO Open 6:100255. https://doi.org/10.1016/j.esmoop.2021.100255 - DOI - PubMed - PMC
#Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (2010) Preoperative/neoadjuvant therapy in__ pancreatic cancer__: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267. https://doi.org/10.1371/journal.pmed.1000267 - DOI - PubMed - PMC
#Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005 - DOI - PubMed
#Tempero MA (2019) NCCN guidelines updates:__ pancreatic cancer__. J Natl Compr Canc Netw 17:603–605. https://doi.org/10.6004/jnccn.2019.5007 - DOI - PubMed
#Clinton SK, Giovannucci EL, Hursting SD (2020) The World Cancer Research Fund/American Institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr 150:663–671. https://doi.org/10.1093/jn/nxz268 - DOI - PubMed
#Qin X, Chen J, Jia G, Yang Z (2023) Dietary factors and__ pancreatic cancer__ risk: an umbrella review of meta-analyses of prospective observational studies. Adv Nutr 14:451–464. https://doi.org/10.1016/j.advnut.2023.02.004 - DOI - PubMed - PMC
#Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S et al (1993) A cohort study of smoking, alcohol consumption, and dietary factors for__ pancreatic cancer__ (United States). Cancer Causes Control 4:477–482. https://doi.org/10.1007/bf00050867 - DOI - PubMed
#Peila R, Coday M, Crane TE, Saquib N, Shadyab AH, Tabung FK, Zhang X et al (2022) Healthy lifestyle index and risk of__ pancreatic cancer__ in the women’s health initiative. Cancer Causes Control 33:737–747. https://doi.org/10.1007/s10552-022-01558-x - DOI - PubMed - PMC
#Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2003) Dietary meat, dairy products, fat, and cholesterol and__ pancreatic cancer__ risk in a prospective study. Am J Epidemiol 157:1115–1125. https://doi.org/10.1093/aje/kwg098 - DOI - PubMed
#Chatterjee R, Fuss P, Vickery EM, LeBlanc ES, Sheehan PR, Lewis MR, Dolor RJ et al (2021) __vitamin__ D supplementation for prevention of cancer: the D2d cancer outcomes (D2dCA) ancillary study. J Clin Endocrinol Metab 106:2767–2778. https://doi.org/10.1210/clinem/dgab153 - DOI - PubMed - PMC
#Haykal T, Samji V, Zayed Y, Gakhal I, Dhillon H, Kheiri B, Kerbage J et al (2019) The role of __vitamin__ D supplementation for primary prevention of cancer: meta-analysis of randomized controlled trials. J Community Hosp Internal Med Persp 9:480–488. https://doi.org/10.1080/20009666.2019.1701839 - DOI
#Reid IR, Bolland MJ, Grey A (2014) Effects of __vitamin__ D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146–155. https://doi.org/10.1016/s0140-6736(13)61647-5 - DOI - PubMed
#Vanhevel J, Verlinden L, Doms S, Wildiers H, Verstuyf A (2022) The role of __vitamin__ D in breast cancer risk and progression. Endocr Relat Cancer 29:R33-r55. https://doi.org/10.1530/erc-21-0182 - DOI - PubMed
#Kim H, Lipsyc-Sharf M, Zong X, Wang X, Hur J, Song M, Wang M et al (2021) Total __vitamin__ D intake and risks of early-onset colorectal cancer and precursors. Gastroenterology 161:1208-1217.e9. https://doi.org/10.1053/j.gastro.2021.07.002 - DOI - PubMed
#Kanaan Y, Copeland RL (2022) The link between __vitamin__ D and prostate cancer. Nat Rev Cancer 22:435. https://doi.org/10.1038/s41568-022-00493-y - DOI - PubMed
#Jones G (2013) Extrarenal __vitamin__ D activation and interactions between __vitamin__ D2, __vitamin__ D3, and __vitamin__ D analogs. Annu Rev Nutr 33:23–44. https://doi.org/10.1146/annurev-nutr-071812-161203 - DOI - PubMed
#Wilson LR, Tripkovic L, Hart KH, Lanham-New SA (2017) __vitamin__ D deficiency as a public health issue: using __vitamin__ D2 or __vitamin__ D3 in future fortification strategies. Proc Nutr Soc 76:392–399. https://doi.org/10.1017/s0029665117000349 - DOI - PubMed
#Holick MF (2004) __vitamin__ D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371. https://doi.org/10.1093/ajcn/79.3.362 - DOI - PubMed
#Green J (1951) Studies on the analysis of __vitamin__s D. 4. Studies on the irradiation of ergosterol and 7-dehydrocholesterol and the analysis of the products for calciferol, __vitamin__ D3, and component sterols. Biochem J 49:232–243. https://doi.org/10.1042/bj0490232 - DOI - PubMed - PMC
#Bikle DD (2014) __vitamin__ D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319–329. https://doi.org/10.1016/j.chembiol.2013.12.016 - DOI - PubMed - PMC
#Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG (2014) __vitamin__ D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2:298–306. https://doi.org/10.1016/s2213-8587(13)70200-6 - DOI - PubMed
#Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD et al (2013) Causal relationship between obesity and __vitamin__ D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383. https://doi.org/10.1371/journal.pmed.1001383 - DOI - PubMed - PMC
#Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of __vitamin__ D in obesity. Am J Clin Nutr 72:690–693. https://doi.org/10.1093/ajcn/72.3.690 - DOI - PubMed
#Savastano S, Barrea L, Savanelli MC, Nappi F, Di Somma C, Orio F, Colao A (2017) Low __vitamin__ D status and obesity: role of nutritionist. Rev Endocr Metab Disord 18:215–225. https://doi.org/10.1007/s11154-017-9410-7 - DOI - PubMed
#Fernandes MR, Barreto WDRJ (2017) Association between physical activity and __vitamin__ D: a narrative literature review. Rev Assoc Med Bras (1993) 63:550–556. https://doi.org/10.1590/1806-9282.63.06.550 - DOI
#Bicakli DH, Uslu R, Güney SC, Coker A (2020) The relationship between nutritional status, performance status, and survival among__ pancreatic cancer__ patients. Nutr Cancer 72:202–208. https://doi.org/10.1080/01635581.2019.1634217 - DOI - PubMed
#Kubiak J, Kamycheva E, Jorde R (2021) Tracking of serum 25-hydroxy__vitamin__ D during 21 years. Eur J Clin Nutr 75:1069–1076. https://doi.org/10.1038/s41430-020-00814-0 - DOI - PubMed
#Borel P, Caillaud D, Cano NJ (2015) __vitamin__ D bioavailability: state of the art. Crit Rev Food Sci Nutr 55:1193–1205. https://doi.org/10.1080/10408398.2012.688897 - DOI - PubMed
#Stolzenberg-Solomon RZ (2009) __vitamin__ D and__ pancreatic cancer__. Ann Epidemiol 19:89–95. https://doi.org/10.1016/j.annepidem.2008.03.010 - DOI - PubMed
#Sanchez GV, Weinstein SJ, Stolzenberg-Solomon RZ (2012) Is dietary fat, __vitamin__ D, or folate associated with__ pancreatic cancer__? Mol Carcinog 51:119–127. https://doi.org/10.1002/mc.20833 - DOI - PubMed - PMC
#Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC (2010) Ultraviolet B irradiance and __vitamin__ D status are inversely associated with incidence rates of__ pancreatic cancer__ worldwide. Pancreas 39:669–674. https://doi.org/10.1097/MPA.0b013e3181ce654d - DOI - PubMed
#Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted __vitamin__ D status and__ pancreatic cancer__ risk in two prospective cohort studies. Br J Cancer 102:1422–1427. https://doi.org/10.1038/sj.bjc.6605658 - DOI - PubMed - PMC
#Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (2006) Prospective study of predictors of __vitamin__ D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459. https://doi.org/10.1093/jnci/djj101 - DOI - PubMed
#Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, Ng K et al (2016) Prediagnostic plasma 25-hydroxy__vitamin__ D and__ pancreatic cancer__ survival. J Clin Oncol 34:2899–2905. https://doi.org/10.1200/jco.2015.66.3005 - DOI - PubMed - PMC
#Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP et al (2004)__ pancreatic cancer__ cells express 25-hydroxy__vitamin__ D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxy__vitamin__ D3. Carcinogenesis 25:1015–1026. https://doi.org/10.1093/carcin/bgh086 - DOI - PubMed
#Pettersson F, Colston KW, Dalgleish AG (2000) Differential and antagonistic effects of 9-cis-retinoic acid and __vitamin__ D analogues on__ pancreatic cancer__ cells in vitro. Br J Cancer 83:239–245. https://doi.org/10.1054/bjoc.2000.1281 - DOI - PubMed - PMC
#Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T et al (1996) Inhibitory effect of 220-oxa-1,25-dihydroxy__vitamin__ D3 on the proliferation of__ pancreatic cancer__ cell lines. Gastroenterology 110:1605–1613. https://doi.org/10.1053/gast.1996.v110.pm8613068 - DOI - PubMed
#Colston KW, James SY, Ofori-Kuragu EA, Binderup L, Grant AG (1997) __vitamin__ D receptors and anti-proliferative effects of __vitamin__ D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 76:1017–1020. https://doi.org/10.1038/bjc.1997.501 - DOI - PubMed - PMC
#van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, Kampman E et al (2018) Circulating concentrations of __vitamin__ D in relation to__ pancreatic cancer__ risk in European populations. Int J Cancer 142:1189–1201. https://doi.org/10.1002/ijc.31146 - DOI - PubMed
#Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ et al (2010) Circulating 25-hydroxy__vitamin__ D and risk of__ pancreatic cancer__: cohort consortium __vitamin__ D pooling project of rarer cancers. Am J Epidemiol 172:81–93. https://doi.org/10.1093/aje/kwq120 - DOI - PubMed - PMC
#Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012) Impact of circulating __vitamin__ D binding protein levels on the association between 25-hydroxy__vitamin__ D and__ pancreatic cancer__ risk: a nested case-control study. Cancer Res 72:1190–1198. https://doi.org/10.1158/0008-5472.Can-11-2950 - DOI - PubMed - PMC
#Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D et al (2000) Meta-analysis of observational studies in epidemiology—ā proposal for reporting. Jama-J Am Med Assoc 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008 - DOI
#Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71 - DOI - PubMed - PMC
#von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD - DOI
#Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z - DOI - PubMed
#Institute of Medicine Committee to Review Dietary Reference Intakes for __vitamin__ D, Calcium (2011) The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press (US) Copyright © 2011, National Academy of Sciences., Washington (DC)
#Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH et al (2011) Evaluation, treatment, and prevention of __vitamin__ D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930. https://doi.org/10.1210/jc.2011-0385 - DOI - PubMed
#Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, Cooper C et al (2022) Role of __vitamin__ D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res 34:2603–2623. https://doi.org/10.1007/s40520-022-02279-6 - DOI - PubMed - PMC
#Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxy__vitamin__ D for multiple health outcomes. Am J Clin Nutr 84:18–28. https://doi.org/10.1093/ajcn/84.1.18 - DOI - PubMed
#DerSimonian R, Laird N (2015) Meta-analysis in clinical trials revisited. Contemp Clin Trials 45:139–145. https://doi.org/10.1016/j.cct.2015.09.002 - DOI - PubMed - PMC
#DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15:1237–48. https://doi.org/10.1002/(SICI)1097-0258(19960630)15:12&lt;1237::AID-SIM301&gt;3.0.CO;2-N - DOI - PubMed
#DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2 - DOI - PubMed
#Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557 - DOI - PubMed - PMC
#Jeon SM, Shin EA (2018) Exploring __vitamin__ D metabolism and function in cancer. Exp Mol Med 50:1–14. https://doi.org/10.1038/s12276-018-0038-9 - DOI - PubMed
#Marigoudar JB, Sarkar D, Yuguda YM, Abutayeh RF, Kaur A, Pati A, Mitra D et al (2022) Role of __vitamin__ D in targeting cancer and cancer stem cell populations and its therapeutic implications. Med Oncol 40:2. https://doi.org/10.1007/s12032-022-01855-0 - DOI - PubMed
#Chiang KC, Chen TC (2009) __vitamin__ D for the prevention and treatment of__ pancreatic cancer__. World J Gastroenterol 15:3349–3354. https://doi.org/10.3748/wjg.15.3349 - DOI - PubMed - PMC
#Mondul AM, Weinstein SJ, Layne TM, Albanes D (2017) __vitamin__ D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev 39:28–48. https://doi.org/10.1093/epirev/mxx005 - DOI - PubMed - PMC
#Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of__ pancreatic cancer__. J Natl Cancer Inst 105:1027–1035. https://doi.org/10.1093/jnci/djt123 - DOI - PubMed - PMC
#Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A (2010) 25-Hydroxy__vitamin__ D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18:1906–1910. https://doi.org/10.1038/oby.2010.11 - DOI - PubMed
#Vaidya A, Williams JS, Forman JP (2012) The independent association between 25-hydroxy__vitamin__ D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) 20:186–191. https://doi.org/10.1038/oby.2011.210 - DOI - PubMed
#Earthman CP, Beckman LM, Masodkar K, Sibley SD (2012) The link between obesity and low circulating 25-hydroxy__vitamin__ D concentrations: considerations and implications. Int J Obes (Lond) 36:387–396. https://doi.org/10.1038/ijo.2011.119 - DOI - PubMed
#McPhail S, Johnson S, Greenberg D, Peake M, Rous B (2015) Stage at diagnosis and early mortality from cancer in England. Br J Cancer 112(Suppl 1):S108–S115. https://doi.org/10.1038/bjc.2015.49 - DOI - PubMed - PMC
#Zwaigenbaum L, Stone W (2008) Early detection. Autism 12:427–432. https://doi.org/10.1177/1362361308097836 - DOI - PubMed
#Fernández-Lázaro D, Seco-Calvo J (2023) Nutrition, nutritional status and functionality. Nutrients. https://doi.org/10.3390/nu15081944 - DOI - PubMed - PMC
#Zhang X, Chen Y, Jin S, Bi X, Chen D, Zhang D, Liu L et al (2020) Association of serum 25-Hydroxy__vitamin__ D with __vitamin__ D intervention and outdoor activity among children in North China: an observational study. BMC Pediatr 20:542. https://doi.org/10.1186/s12887-020-02435-9 - DOI - PubMed - PMC
#Holick MF (2017) The __vitamin__ D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18:153–165. https://doi.org/10.1007/s11154-017-9424-1 - DOI - PubMed
#Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, Stolzenberg-Solomon RZ et al (2018) Circulating 25-hydroxy__vitamin__ D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol 33:1087–1099. https://doi.org/10.1007/s10654-018-0428-2 - DOI - PubMed - PMC
#Rasmussen LS, Yilmaz MK, Falkmer UG, Poulsen L, Bøgsted M, Christensen HS, Bojesen SE et al (2021) Pre-treatment serum __vitamin__ D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with__ pancreatic cancer__. Eur J Cancer 144:72–80. https://doi.org/10.1016/j.ejca.2020.10.038 - DOI - PubMed
#Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, Schulz C et al (2015) Assessing novel prognostic serum biomarkers in advanced__ pancreatic cancer__: the role of CYFRA 21–1, serum amyloid A, haptoglobin, and 25-OH __vitamin__ D3. Tumour Biol 36:2631–2640. https://doi.org/10.1007/s13277-014-2885-x - DOI - PubMed
#McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB (2016) Retrospective analysis of the influence of 25-hydroxy__vitamin__ D on disease progression and survival in__ pancreatic cancer__. Nutr J 15:17. https://doi.org/10.1186/s12937-016-0135-3 - DOI - PubMed - PMC
#LeFevre ML (2015) Screening for __vitamin__ D deficiency in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 162:133–140. https://doi.org/10.7326/m14-2450 - DOI - PubMed
#Kantor ED, Rehm CD, Du M, White E, Giovannucci EL (2016) Trends in dietary supplement use among US adults from 1999–2012. JAMA 316:1464–1474. https://doi.org/10.1001/jama.2016.14403 - DOI - PubMed - PMC
#Adams JS, Hewison M (2012) Extrarenal expression of the 25-hydroxy__vitamin__ D-1-hydroxylase. Arch Biochem Biophys 523:95–102. https://doi.org/10.1016/j.abb.2012.02.016 - DOI - PubMed - PMC
#Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C (1996) Growth-inhibitory effects of __vitamin__ D analogues and retinoids on human__ pancreatic cancer__ cells. Br J Cancer 73:1341–1346. https://doi.org/10.1038/bjc.1996.256 - DOI - PubMed - PMC
#Schwartz GG, Eads D, Naczki C, Northrup S, Chen T, Koumenis C (2008) 19-nor-1 alpha,25-dihydroxy__vitamin__ D2 (paricalcitol) inhibits the proliferation of human__ pancreatic cancer__ cells in vitro and in vivo. Cancer Biol Ther 7:430–436. https://doi.org/10.4161/cbt.7.3.5418 - DOI - PubMed
#Albrechtsson E, Jonsson T, Möller S, Höglund M, Ohlsson B, Axelson J (2003) __vitamin__ D receptor is expressed in__ pancreatic cancer__ cells and a __vitamin__ D3 analogue decreases cell number. Pancreatology 3:41–46. https://doi.org/10.1159/000069149 - DOI - PubMed
#Armas LA, Hollis BW, Heaney RP (2004) __vitamin__ D2 is much less effective than __vitamin__ D3 in humans. J Clin Endocrinol Metab 89:5387–5391. https://doi.org/10.1210/jc.2004-0360 - DOI - PubMed
#Skinner HG (2008) __vitamin__ D for the treatment and prevention of__ pancreatic cancer__. Cancer Biol Ther 7:437–439. https://doi.org/10.4161/cbt.7.3.5585 - DOI - PubMed
#Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA et al (2014) __vitamin__ D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances__ pancreatic cancer__ therapy. Cell 159:80–93. https://doi.org/10.1016/j.cell.2014.08.007 - DOI - PubMed - PMC
#Hennig R, Ding XZ, Adrian TE (2004) On the role of the islets of Langerhans in__ pancreatic cancer__. Histol Histopathol 19:999–1011. https://doi.org/10.14670/hh-19.999
#Bear AS, Vonderheide RH, O’Hara MH (2020) Challenges and opportunities for__ pancreatic cancer__ immunotherapy. Cancer Cell 38:788–802. https://doi.org/10.1016/j.ccell.2020.08.004 - DOI - PubMed - PMC
#Maestro B, Molero S, Bajo S, Dávila N, Calle C (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxy__vitamin__ D(3). Cell Biochem Funct 20:227–232. https://doi.org/10.1002/cbf.951 - DOI - PubMed
#Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxy__vitamin__ D3 receptors in human leukocytes. Science 221:1181–1183. https://doi.org/10.1126/science.6310748 - DOI - PubMed
#Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxy__vitamin__ D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657–661. https://doi.org/10.1172/jci111465 - DOI - PubMed - PMC
#Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxy__vitamin__ D3 on human B cell differentiation. J Immunol 179:1634–1647. https://doi.org/10.4049/jimmunol.179.3.1634 - DOI - PubMed
#Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of __vitamin__ D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932. https://doi.org/10.1002/jcb.10580 - DOI - PubMed
#Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) __vitamin__ D: modulator of the immune system. Curr Opin Pharmacol 10:482–496. https://doi.org/10.1016/j.coph.2010.04.001 - DOI - PubMed
#Mora JR, Iwata M, von Andrian UH (2008) __vitamin__ effects on the immune system: __vitamin__s A and D take centre stage. Nat Rev Immunol 8:685–698. https://doi.org/10.1038/nri2378 - DOI - PubMed - PMC
#Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC (1985) 1,25-Dihydroxy__vitamin__ D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134:3032–3035 - DOI - PubMed
#Schlingmann KP (2021) __vitamin__ D-dependent Hypercalcemia. Endocrinol Metab Clin North Am 50:729–742. https://doi.org/10.1016/j.ecl.2021.08.005 - DOI - PubMed
#Tebben PJ, Singh RJ, Kumar R (2016) __vitamin__ D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37:521–547. https://doi.org/10.1210/er.2016-1070 - DOI - PubMed - PMC
#Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S et al (2009) Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice–the ECHO observational study. Nephrol Dial Transpl 24:2852–2859. https://doi.org/10.1093/ndt/gfp144 - DOI
#Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ et al (2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70:351–357. https://doi.org/10.1038/sj.ki.5001542 - DOI - PubMed

---
!!!!VitaminDWiki – ((Cancer - Pancreatic)) category contains
{include page=&quot;Cancer - Pancreatic&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
---
!!!!~~#F06:81+~~  VitaminDWiki Cancer meta-analyses
&#39;&#39;This list is automatically updated&#39;&#39;
{LIST()}
{list max=&quot;150&quot;}
{filter categories=&quot;82&quot;}
{filter field=&quot;title&quot; content=&quot;cancer&quot;}
{filter type=&quot;wiki page&quot;}
{sort mode=&quot;modification_date_major_desc&quot;}
{OUTPUT(template=&quot;table&quot;)}
   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}n
    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}
    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}
{OUTPUT}
{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}
{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}
{LIST}

~tc~ (alias(Pancreatic Cancer survival 2.3 X more likely if good level of Vitamin D – meta-analysis  Sept 2023)) ~/tc~
</code>
</pre>
